<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1348" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1348/" /><meta name="ncbi_pagename" content="Congenital Fibrosis of the Extraocular Muscles - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Congenital Fibrosis of the Extraocular Muscles - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Congenital Fibrosis of the Extraocular Muscles" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/14" /><meta name="citation_author" content="Mary Whitman" /><meta name="citation_author" content="David G Hunter" /><meta name="citation_author" content="Elizabeth C Engle" /><meta name="citation_pmid" content="20301522" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1348/" /><meta name="citation_keywords" content="CFEOM" /><meta name="citation_keywords" content="CFEOM" /><meta name="citation_keywords" content="Tukel Syndrome" /><meta name="citation_keywords" content="Kinesin-like protein KIF21A" /><meta name="citation_keywords" content="Paired mesoderm homeobox protein 2A" /><meta name="citation_keywords" content="Tubulin beta-2B chain" /><meta name="citation_keywords" content="Tubulin beta-3 chain" /><meta name="citation_keywords" content="KIF21A" /><meta name="citation_keywords" content="PHOX2A" /><meta name="citation_keywords" content="TUBB2B" /><meta name="citation_keywords" content="TUBB3" /><meta name="citation_keywords" content="Congenital Fibrosis of the Extraocular Muscles" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Congenital Fibrosis of the Extraocular Muscles" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Mary Whitman" /><meta name="DC.Contributor" content="David G Hunter" /><meta name="DC.Contributor" content="Elizabeth C Engle" /><meta name="DC.Date" content="2016/01/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1348/" /><meta name="description" content="Congenital fibrosis of the extraocular muscles (CFEOM) refers to at least eight genetically defined strabismus syndromes (CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria) characterized by congenital non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). In general, affected individuals have severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze. Individuals with CFEOM frequently compensate for the ophthalmoplegia by maintaining abnormal head positions at rest and by moving their heads rather than their eyes to track objects. Individuals with CFEOM3A may also have intellectual disability, social disability, Kallmann syndrome, facial weakness, and vocal cord paralysis; and/or may develop a progressive sensorimotor axonal polyneuropathy. Individuals with Tukel syndrome also have postaxial oligodactyly or oligosyndactyly of the hands. Those with CFEOM3 with polymicrogyria also have microcephaly and intellectual disability." /><meta name="og:title" content="Congenital Fibrosis of the Extraocular Muscles" /><meta name="og:type" content="book" /><meta name="og:description" content="Congenital fibrosis of the extraocular muscles (CFEOM) refers to at least eight genetically defined strabismus syndromes (CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria) characterized by congenital non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). In general, affected individuals have severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze. Individuals with CFEOM frequently compensate for the ophthalmoplegia by maintaining abnormal head positions at rest and by moving their heads rather than their eyes to track objects. Individuals with CFEOM3A may also have intellectual disability, social disability, Kallmann syndrome, facial weakness, and vocal cord paralysis; and/or may develop a progressive sensorimotor axonal polyneuropathy. Individuals with Tukel syndrome also have postaxial oligodactyly or oligosyndactyly of the hands. Those with CFEOM3 with polymicrogyria also have microcephaly and intellectual disability." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1348/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cfeom/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1348/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DD279E040775100000000046A019D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1348_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1348_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cftd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hepatic-fibrosis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1348_"><span class="title" itemprop="name">Congenital Fibrosis of the Extraocular Muscles</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: CFEOM</div><p class="contrib-group"><span itemprop="author">Mary Whitman</span>, MD, PhD, <span itemprop="author">David G Hunter</span>, MD, PhD, and <span itemprop="author">Elizabeth C Engle</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1348_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1348_ai__"><div class="contrib half_rhythm"><span itemprop="author">Mary Whitman</span>, MD, PhD<div class="affiliation small">Department of Ophthalmology, Boston Children's Hospital<br />Instructor in Ophthalmology, Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@namtihw.yram" class="oemail">ude.dravrah.snerdlihc@namtihw.yram</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David G Hunter</span>, MD, PhD<div class="affiliation small">Ophthalmologist-in-Chief, Boston Children's Hospital<br />Professor of Ophthalmology, Harvard Medical School<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@retnuh.divad" class="oemail">ude.dravrah.snerdlihc@retnuh.divad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Elizabeth C Engle</span>, MD<div class="affiliation small">Department of Neurology<br />Children's Hospital Boston<br />Professor of Neurology and Ophthalmology, Harvard Medical School<br />Boston, Massachusetts</div><div class="affiliation small">Howard Hughes Medical Institute<br />Chevy Chase, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@elgne.htebazile" class="oemail">ude.dravrah.snerdlihc@elgne.htebazile</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 27, 2004</span>; Last Update: <span itemprop="dateModified">January 14, 2016</span>.</p><p><em>Estimated reading time: 35 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cfeom.Summary" itemprop="description"><h2 id="_cfeom_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Congenital fibrosis of the extraocular muscles (CFEOM) refers to at least eight genetically defined strabismus syndromes (CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria) characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). In general, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze. Individuals with CFEOM frequently compensate for the ophthalmoplegia by maintaining abnormal head positions at rest and by moving their heads rather than their eyes to track objects. Individuals with CFEOM3A may also have intellectual disability, social disability, Kallmann syndrome, facial weakness, and vocal cord paralysis; and/or may develop a progressive sensorimotor axonal polyneuropathy. Individuals with Tukel syndrome also have postaxial oligodactyly or oligosyndactyly of the hands. Those with CFEOM3 with polymicrogyria also have microcephaly and intellectual disability.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CFEOM is based on ophthalmologic findings, and the subtypes depend on the identification of specific eye findings and associated findings. <i>KIF21A</i> pathogenic variants are associated with CFEOM1A and CFEOM3B. <i>PHOX2A</i> pathogenic variants are associated with CFEOM2. <i>TUBB3</i> pathogenic variants are associated with CFEOM3A and CFEOM1B. <i>TUBB2B</i> pathogenic variants are associated with CFEOM3A and CFEOM3 with polymicrogyria.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Refractive errors may be managed with glasses or contact lenses. Amblyopia can be treated effectively with occlusion or penalization of the better-seeing eye. Corneal lubrication may be helpful. Corrective eye muscle and/or ptosis surgery may be required.</p><p><i>Prevention of secondary complications:</i> Amblyopia therapy to prevent vision loss in the less-preferred eye.</p><p><i>Surveillance:</i> To prevent and treat amblyopia and to address complications of corneal exposure: routine ophthalmologic care with visits every three to four months during the first years of life, and annual or biannual examinations in older <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals not at risk for amblyopia. In individuals with specific <i>TUBB3</i> variants, surveillance for endocrine abnormalities, facial or vocal cord weakness, and interventions for developmental delays are indicated.</p><p><i>Evaluation of relatives at risk:</i> Early clinical diagnosis can lead to early treatment and prevention of secondary complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CFEOM is inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (CFEOM1, CFEOM3, and CFEOM3 with polymicrogyria) or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (CFEOM2 and Tukel syndrome) manner.</p><ul><li class="half_rhythm"><div>CFEOM1, CFEOM3, and CFEOM3 with polymicrogyria. An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have inherited a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from an affected parent or have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant. Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CFEOM has a 50% chance of inheriting the pathogenic variant.</div></li><li class="half_rhythm"><div>CFEOM2 and Tukel syndrome. The parents of a child with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> CFEOM are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li></ul><p>Prenatal testing for pregnancies at increased risk is possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="cfeom.Diagnosis"><h2 id="_cfeom_Diagnosis_">Diagnosis</h2><p>The term <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> fibrosis of the extraocular muscles (CFEOM) refers to several syndromes: CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B, CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria [<a class="bk_pop" href="#cfeom.REF.doherty.1999.1687">Doherty et al 1999</a>, <a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.aubourg.2005.253">Aubourg et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.tukel.2005.408">Tukel et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.karadeniz.2009.e570">Karadeniz et al 2009</a>, <a class="bk_pop" href="#cfeom.REF.khan.2010.154">Khan et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</a>].</p><div id="cfeom.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Congenital fibrosis of the extraocular muscles (CFEOM) <b>should be suspected</b> in individuals with the following clinical features:</p><ul><li class="half_rhythm"><div>Congenital non-progressive ophthalmoplegia (inability to move the eyes) typically with severe limitation of vertical gaze (usually upgaze) and variable limitation of horizontal gaze</div></li><li class="half_rhythm"><div>Ptosis (droopy eyelids) that may range from mild to profound, and can be unilateral</div></li></ul><p>The condition affects part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique).</p><p>Typically binocular vision is absent. Refractive errors are common.</p><p>Note: For complete description of the eye findings to aid in establishing the diagnosis of a specific form of CFEOM, see <a class="figpopup" href="/books/NBK1348/table/cfeom.T.comparison_of_types_of_cfeom/?report=objectonly" target="object" rid-figpopup="figcfeomTcomparisonoftypesofcfeom" rid-ob="figobcfeomTcomparisonoftypesofcfeom">Table 1</a>.</p><div id="cfeom.T.comparison_of_types_of_cfeom" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Comparison of Types of CFEOM</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.T.comparison_of_types_of_cfeom/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.T.comparison_of_types_of_cfeom_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM1</th><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM2</th><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM3</th><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tukel Syndrome</th><th id="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM3 w/Polymicrogyria</th></tr></thead><tbody><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>External ophthalmo-</b><br /><b>plegia</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital, non-progressive. bilateral, profound, w/limited upgaze</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital, non-progressive, bilateral, profound, w/eyes in exotropic (outward deviating) position</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital, non-progressive, bilateral OR unilateral; primarily affecting muscles in the oculomotor distribution&#x000a0;<sup>1</sup></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital, non-progressive, bilateral OR unilateral; primarily affecting muscles in the oculomotor distribution&#x000a0;<sup>1</sup></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital, non-progressive, bilateral; limited upgaze</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Lid position</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital non-progressive bilateral ptosis</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital non-progressive bilateral ptosis</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal OR <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> non-progressive bilateral or unilateral ptosis</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal OR <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> non-progressive bilateral or unilateral ptosis</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital non-progressive bilateral ptosis</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Primary vertical position of each eye</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infraducted (downward)</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or positioned slightly above or below midline</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infraducted or normal (primary position)</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infraducted or normal (primary position)</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infraducted</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vertical eye movements</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Inability to elevate eyes above horizontal midline</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely restricted</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable restriction w/ or w/out upgaze above midline</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variable restriction w/ or w/out upgaze above midline</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely limited</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Primary horizontal position of each eye</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthotropic (normal), esotropic (inward), or exotropic (outward)</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically exotropic; rarely, orthotropic</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthotropic or exotropic more frequent than esotropic</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthotropic or exotropic may be more frequent than esotropic</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orthotropic or exotropic</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Horizontal eye movements</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to severely restricted</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely restricted; only abduction preserved</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to severely restricted</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to severely restricted</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variably restricted</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Aberrant eye movements</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent, especially both eyes turning inward on attempted upgaze</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Small amplitude, if present</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sometimes present</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sometimes present</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Convergent nystagmus w/attempted upgaze</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Forced duction test</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive for restriction</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive for restriction</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive for restriction at least in attempted upgaze</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive for restriction at least in attempted upgaze</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Positive for restriction</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Binocular vision</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually absent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rarely present</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rarely present</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually absent</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Refractive errors</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequently high astigmatism</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent, high astigmatism</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Amblyopia</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent; may be strabismic or refractive in nature</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pupils</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Often small &#x00026; sluggishly reactive to light</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Typically normal, occasionally small &#x00026; sluggish</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family history</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consistent w/AD inheritance; <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases&#x000a0;<sup>2</sup> observed; parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> can mimic AR inheritance</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consistent w/AR inheritance</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consistent w/AD inheritance; <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases&#x000a0;<sup>2</sup> observed; parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> can mimic AR inheritance</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consistent w/AR inheritance</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consistent w/AD inheritance</td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genetics</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM1A: associated w/pathogenic variants in <i>KIF21A</i><br />CFEOM1B: associated w/path variants in <i>TUBB3</i></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Associated w/path variants in <i>PHOX2A</i></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CFEOM3A: associated w/path variants in <i>TUBB3</i> or <i>TUBB2B</i><br />CFEOM3B: associated w/path variants in <i>KIF21A</i><br />CFEOM3C: refers to cosegregation of CFEOM3 w/a <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> (in 1 family)</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Associated w/path variants in <i>TUBB2B</i></td></tr><tr><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Additional findings</b></td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Retinal dysfunction</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variably present in CFEOM3A:<br />intellectual &#x00026; social disability, facial weakness, vocal cord paralysis, Kallmann syndrome, cyclic vomiting, spasticity, progressive sensorimotor axonal polyneuropathy<br />On brain MRI:<br />malformations of cortical development; dysgenesis of: corpus callosum, anterior commissure, corticospinal tracts, &#x00026; basal ganglia<br />On MRI of cranial nerves &#x00026; orbits:<br />hypoplasia of the oculomotor nerve &#x00026; levator/superior rectus muscles</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Postaxial oligodactyly or oligosyndactyly of the hands;<br />In one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person w/an unbalanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>: facial dysmorphisms, kyphosis, pectus excavatum, developmental delay, &#x00026; motor regression</td><td headers="hd_h_cfeom.T.comparison_of_types_of_cfeom_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intellectual disability,<br />polymicrogyria,<br />microcephaly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt>1. </dt><dd><div id="cfeom.TF.1.1"><p class="no_margin">In individuals not meeting CFEOM1 criteria</p></div></dd><dt>2. </dt><dd><div id="cfeom.TF.1.2"><p class="no_margin">A single occurrence in a family</p></div></dd></dl></div></div></div></div><div id="cfeom.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CFEOM <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of a specific CFEOM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and/or of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KIF21A, TUBB3</i>, or <i>TUBB2B</i> or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PHOX2A</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1348/table/cfeom.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figcfeomTmoleculargenetictestingusedi" rid-ob="figobcfeomTmoleculargenetictestingusedi">Table 2</a>).</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> can be considered if (1) a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a particular gene accounts for a large proportion of the disease OR (2) additional factors (e.g., clinical findings, laboratory findings, and ancestry) indicate that a pathogenic variant in a particular gene is most likely. Sequence analysis of the gene of interest is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no pathogenic variant is found.</p><ul><li class="half_rhythm"><div>For patients with a CFEOM1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KIF21A</i>, followed by sequence analysis of <i>TUBB3</i> should be performed. All disease-associated alleles reported in <i>KIF21A</i> and <i>TUBB3</i> have been <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; thus, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is not recommended.</div></li><li class="half_rhythm"><div>For patients with the CFEOM2 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>PHOX2A</i> should be performed, followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div>For patients with a CFEOM3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TUBB3</i> should be performed first, followed by sequence analysis of <i>KIF21A</i>. All disease-associated alleles reported in <i>KIF21A</i> and <i>TUBB3</i> have been <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; thus, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is not recommended.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KIF21A, TUBB3, TUBB2B, PHOX2A,</i> and other genes of interest (see <a href="#cfeom.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>KIF21A, TUBB3, TUBB2B,</i> and <i>PHOX2A</i>) fails to confirm a diagnosis in an individual with features of CFEOM. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cfeom.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in CFEOM</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of CFEOM Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3" id="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF21A</i></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~55%</td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">81/94 in CFEOM1&#x000a0;<sup>5</sup><br />5/20 in CFEOM3&#x000a0;<sup>6</sup></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB3</i></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~35%</td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/15 in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> CFEOM3&#x000a0;<sup>8</sup><br />27/27 in CFEOM3 with additional neurologic findings&#x000a0;<sup>9</sup></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PHOX2A</i></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%</td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/15 in CFEOM2&#x000a0;<sup>10</sup></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB2B</i></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3 in CFEOM3 with polymicrogyria&#x000a0;<sup>11</sup></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>12</sup></td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_1_3 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_1 hd_h_cfeom.T.molecular_genetic_testing_used_i_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cfeom.TF.2.1"><p class="no_margin">See <a href="/books/NBK1348/#cfeom.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cfeom.TF.2.2"><p class="no_margin">See <a href="#cfeom.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cfeom.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cfeom.TF.2.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="cfeom.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al [2003]</a>, <a class="bk_pop" href="#cfeom.REF.ali.2004.247">Ali et al [2004]</a>, <a class="bk_pop" href="#cfeom.REF.tiab.2004.241">Tiab et al [2004]</a>, <a class="bk_pop" href="#cfeom.REF.traboulsi.2004.237">Traboulsi &#x00026; Engle [2004]</a>, <a class="bk_pop" href="#cfeom.REF.lin.2005.245">Lin et al [2005]</a>, <a class="bk_pop" href="#cfeom.REF.shimizu.2005.443">Shimizu et al [2005]</a>, <a class="bk_pop" href="#cfeom.REF.yamada.2005.1254">Yamada et al [2005]</a>, <a class="bk_pop" href="#cfeom.REF.chan.2007.26">Chan et al [2007]</a>, <a class="bk_pop" href="#cfeom.REF.karadeniz.2009.e570">Karadeniz et al [2009]</a>, <a class="bk_pop" href="#cfeom.REF.rudolph.2009.667">Rudolph et al [2009]</a>, <a class="bk_pop" href="#cfeom.REF.yang.2010.2062">Yang et al [2010]</a>, <a class="bk_pop" href="#cfeom.REF.khan.2011.218">Khan et al [2011]</a>, <a class="bk_pop" href="#cfeom.REF.wang.2011.973">Wang et al [2011]</a>, <a class="bk_pop" href="#cfeom.REF.luk.2013.182">Luk et al [2013]</a>, <a class="bk_pop" href="#cfeom.REF.ying.2013.63">Ying et al [2013]</a>, <a class="bk_pop" href="#cfeom.REF.ali.2014.368">Ali et al [2014]</a>, <a class="bk_pop" href="#cfeom.REF.ka_ar_bayram.2015.743">Ka&#x000e7;ar Bayram et al [2015]</a></p></div></dd><dt>6. </dt><dd><div id="cfeom.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#cfeom.REF.yamada.2004.2218">Yamada et al [2004]</a>, <a class="bk_pop" href="#cfeom.REF.lin.2005.245">Lin et al [2005]</a>, <a class="bk_pop" href="#cfeom.REF.lu.2008.388">Lu et al [2008]</a>, <a class="bk_pop" href="#cfeom.REF.yang.2010.2062">Yang et al [2010]</a></p></div></dd><dt>7. </dt><dd><div id="cfeom.TF.2.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>8. </dt><dd><div id="cfeom.TF.2.8"><p class="no_margin">Individuals who have the eye <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> only, with no additional medical conditions. <i>TUBB3</i> pathogenic variants are associated with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> occurrences of CFEOM3 [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>]; this is referred to as CFEOM3A. <i>TUBB3</i> pathogenic variants are also a rare cause of CFEOM1; this is referred to as CFEOM1B.</p></div></dd><dt>9. </dt><dd><div id="cfeom.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al [2010]</a>, <a class="bk_pop" href="#cfeom.REF.chew.2013.522">Chew et al [2013]</a>, <a class="bk_pop" href="#cfeom.REF.mackinnon.2014.1461">MacKinnon et al [2014]</a>, <a class="bk_pop" href="#cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al [2015]</a>, <a class="bk_pop" href="#cfeom.REF.whitman.2016.297">Whitman et al [2016]</a></p></div></dd><dt>10. </dt><dd><div id="cfeom.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al [2001]</a>, <a class="bk_pop" href="#cfeom.REF.yazdani.2003.861">Yazdani et al [2003]</a>. <i>PHOX2A</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause the CFEOM2 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.bosley.2006.2363">Bosley et al 2006</a>].</p></div></dd><dt>11. </dt><dd><div id="cfeom.TF.2.11"><p class="no_margin"><a class="bk_pop" href="#cfeom.REF.cederquist.2012.5484">Cederquist et al [2012]</a></p></div></dd><dt>12. </dt><dd><div id="cfeom.TF.2.12"><p class="no_margin">A three-generation family that cosegregated CFEOM3 and a balanced/unbalanced reciprocal <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> t(2;13) (q37.3;q12.11) permitted assignment of CFEOM3C, (OMIM <a href="http://omim.org/entry/609384" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609384</a>) to 13q27.3 [<a class="bk_pop" href="#cfeom.REF.aubourg.2005.253">Aubourg et al 2005</a>]. A genome-wide linkage screen of a large <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family whose <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members have a CFEOM3 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and postaxial oligodactyly/oligosyndactyly of the hands, referred to as Tukel syndrome (OMIM <a href="http://www.omim.org/entry/609428" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609428</a>), mapped the <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> to a 1.5-Mb region on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 21qter [<a class="bk_pop" href="#cfeom.REF.tukel.2005.408">Tukel et al 2005</a>]. See also <a class="bk_pop" href="#cfeom.REF.shinwari.2015.147">Shinwari et al [2015]</a>.</p></div></dd></dl></div></div></div></div></div><div id="cfeom.Clinical_Characteristics"><h2 id="_cfeom_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cfeom.Clinical_Description"><h3>Clinical Description</h3><p>Congenital fibrosis of the extraocular muscles (CFEOM) refers to complex strabismus (eye misalignment) syndromes characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> non-progressive ophthalmoplegia (inability to move the eyes) with or without ptosis (droopy eyelids) affecting part or all of the oculomotor nucleus and nerve (cranial nerve III) and its innervated muscles (superior, medial, and inferior recti, inferior oblique, and levator palpabrae superioris) and/or the trochlear nucleus and nerve (cranial nerve IV) and its innervated muscle (the superior oblique). Magnetic resonance imaging (MRI) suggests that the abducens and optic nerves can also be hypoplastic [<a class="bk_pop" href="#cfeom.REF.demer.2005.530">Demer et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.wu.2009.971">Wu et al 2009</a>, <a class="bk_pop" href="#cfeom.REF.demer.2010.4600">Demer et al 2010</a>].</p><p><b>Strabismus</b> is the deviation of the position of one eye relative to the other, resulting in misalignment of the line of site of the two eyes. Individuals with CFEOM typically have incomitant strabismus, in which their misalignment varies with gaze direction. Incomitant strabismus often results from mechanical dysfunction in the orbit or neuromuscular dysfunction at the level of the brain stem, nerve, or muscle. The resting eye position of an individual with CFEOM is often abnormal. In general, hypotropic (downward) and exotropic (outward) positions are more common than hypertropic (upward) and esotropic (inward) positions. Strabismus in individuals with CFEOM can vary within a single family, and this can be particularly remarkable among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of families with CFEOM3. Among families with CFEOM1, the vertical strabismus is quite uniform, but the horizontal strabismus can vary.</p><p><b>Congenital non-progressive external ophthalmoplegia.</b> Individuals with CFEOM are born with a severe form of incomitant strabismus referred to as ophthalmoplegia (inability to move the eyes) caused by dysfunction of specific ocular muscles innervated by the oculomotor and trochlear nerves. In general, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have severe limitation of vertical gaze and variable limitation of horizontal gaze. Individuals with CFEOM compensate for the ophthalmoplegia by maintaining an abnormal head position at rest and by moving their heads rather than their eyes to track objects.</p><p><b>Ptosis</b> is the drooping of the upper eyelid as a result of dysfunction of the levator palpabrae superioris. Individuals with CFEOM often have a compensatory chin-up head posture to both better position their infraducted eyes and to "see under" their droopy lids.</p><p><b>Refractive errors</b> are common but not characteristic.</p><p><b>Amblyopia.</b> Strabismus (with suppression of one eye), refractive error, and ptosis may cause amblyopia, which can lead to permanent loss of vision when untreated.</p><p><b>CNS malformations.</b> Some individuals with CFEOM have been reported to have central nervous system malformations, including agenesis or hypoplasia of the corpus callosum, brain stem hypoplasia, cerebellar hemisphere hypoplasia, absence of the cerebral peduncle in the midbrain, colpocephaly, hypoplasia of the cerebellar vermis, expansion of the ventricular system, pachygyria, polymicrogyria, encephalocele, and/or hydrancephaly [<a class="bk_pop" href="#cfeom.REF.flaherty.2001.1313">Flaherty et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.pieh.2003.546">Pieh et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.harissidagher.2004.540">Harissi-Dagher et al 2004</a>]. The CFEOM <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in most of these individuals is atypical and meets the criteria of CFEOM3. Other CNS findings include hypoplastic oculomotor nerves, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> basal ganglia with or without internal capsule hypoplasia, and agenesis or hypoplasia of the anterior commissure [<a class="bk_pop" href="#cfeom.REF.demer.2010.4600">Demer et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</a>, <a class="bk_pop" href="#cfeom.REF.chew.2013.522">Chew et al 2013</a>, <a class="bk_pop" href="#cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al 2015</a>, <a class="bk_pop" href="#cfeom.REF.whitman.2016.297">Whitman et al 2016</a>].</p><p><b>Non-ocular findings</b> in a subset of individuals with CFEOM3 include facial paralysis, spasticity, cognitive and behavioral impairments, and a later-onset progressive peripheral sensorimotor axonal polyneuropathy, joint contractures, Kallmann syndrome (hypogonadotropic hypogonadism with anosmia), and cyclic vomiting [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.chew.2013.522">Chew et al 2013</a>].</p><p><b>Marcus Gunn phenomenon and other evidence of misinnervation</b> have been reported in individuals with CFEOM [<a class="bk_pop" href="#cfeom.REF.pieh.2003.546">Pieh et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.yamada.2005.1254">Yamada et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.ka_ar_bayram.2015.743">Ka&#x000e7;ar Bayram et al 2015</a>]. The Marcus Gunn jaw winking phenomenon manifests as the momentary elevation of a ptotic upper eyelid with specific movements of the jaw. Often first noted in young infants when they are feeding, the phenomenon results from aberrant innervation of the levator palpebrae superioris muscle by axons intended to run in the motor branch of the trigeminal nerve and to innervate the pterygoid muscle. The association of this finding with CFEOM provides additional evidence that these syndromes are primarily neurogenic in cause [<a class="bk_pop" href="#cfeom.REF.brodsky.1998.717">Brodsky 1998</a>, <a class="bk_pop" href="#cfeom.REF.pieh.2003.546">Pieh et al 2003</a>].</p><p><b>Tukel syndrome.</b> Affected members of the family with CFEOM3 that maps to the Tukel syndrome <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> also manifest bilateral postaxial oligodactyly/oligosyndactyly of the hands, more severe on the right.</p></div><div id="cfeom.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Each form of CFEOM has a defined <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b><i>KIF21A</i></b> pathogenic variants are associated with CFEOM1 and rare cases of CFEOM3. Clinical examinations and high-resolution orbital MRI of individuals with CFEOM1 resulting from several different specific <i>KIF21A</i> pathogenic variants did not reveal a correlation between any specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.demer.2005.530">Demer et al 2005</a>].</p><p><b><i>PHOX2A</i></b> pathogenic variants are associated with CFEOM2. No correlation between specific <i>PHOX2A</i> pathogenic variants and specific aspects of the CFEOM2 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been found.</p><p><b><i>TUBB3</i></b> pathogenic variants are associated with CFEOM1B or CFEOM3. Correlations have been found between specific <i>TUBB3A</i> pathogenic variants and the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.chew.2013.522">Chew et al 2013</a>, <a class="bk_pop" href="#cfeom.REF.whitman.2016.297">Whitman et al 2016</a>]:</p><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.185G&#x0003e;A</a> (p.Arg62Gln): moderate CFEOM3. Brain MRI: normal. No developmental delays or intellectual disability.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.784C&#x0003e;T</a> (p.Arg262Cys): mild to severe CFEOM3 or CFEOM1B. Brain MRI: anterior commissure hypoplasia, mild corpus callosum hypoplasia, mild basal ganglia dysgenesis. No developmental delays or intellectual disability.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.785G&#x0003e;A</a> (p.Arg262His): severe CFEOM3, developmental delay, facial weakness, progressive axonal sensorimotor polyneuropathy, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> joint contractures. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.904G&#x0003e;A</a> (p.Ala302Thr): variable CFEOM3, developmental delay. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.1138C&#x0003e;T</a> (p.Arg380Cys): moderate CFEOM3, developmental delay. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.1249G&#x0003e;A</a> (p.Asp417Asn): mild to severe CFEOM3 or CFEOM1B, weakness, progressive axonal sensorimotor polyneuropathy. Brain MRI: anterior commissure hypoplasia, mild corpus callosum hypoplasia, mild basal ganglia dysgenesis.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.1249G&#x0003e;C</a> (p.Asp417His): severe CFEOM3, developmental delay, facial weakness, progressive axonal sensorimotor polyneuropathy, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> joint contractures. Brain MRI: anterior commissure hypoplasia.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.1228G&#x0003e;A</a> (p.Glu410Lys): severe CFEOM3, developmental delay, facial weakness, midface hypoplasia, Kallmann syndrome (hypogonadotropic hypogonadism with anosmia), progressive sensorimotor polyneuropathy, vocal cord paralysis, and cyclic vomiting. Brain MRI: anterior commissure hypoplasia, corpus callosum hypoplasia, basal ganglia dysgenesis, hypoplastic to absent olfactory bulbs, olfactory sulci, and oculomotor and facial nerves.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.211G&#x0003e;A</a> (p.Gly71Arg): moderate CFEOM3, developmental delay, hypotonia, thinning or agenesis of corpus callosum, increased and abnormal cortical gyration, basal ganglia and thalamus dysgenesis, brain stem hypoplasia, incomplete rotation of hippocampus, hypoplasia of optic and oculomotor nerves</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedtubb3pathogenicvarian" rid-ob="figobcfeomTselectedtubb3pathogenicvarian">c.292G&#x0003e;A</a> (p.Gly98Ser): moderate CFEOM3, developmental delay, hypotonia, thinning of corpus callosum, increased and abnormal cortical gyration, basal ganglia and thalamus dysgenesis, brain stem hypoplasia, incomplete rotation of hippocampus, cerebellar vermis hypoplasia with <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> folia, hypoplasia of optic and oculmotor nerves</div></li></ul><p>Many persons with CFEOM3 who have a <i>TUBB3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> also have aberrant eye movements and several have ptotic eyelid elevation associated with synkinetic jaw movements (Marcus Gunn phenomenon). However, the Marcus Gunn phenomenon has also been reported in association with a <i>KIF21A</i> -related CFEOM.</p><p><b><i>TUBB2B.</i></b> Only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.1261G&#x0003e;A, p.Glu421Lys) has been associated with both CFEOM and polymicrogyria. Seven other pathogenic variants are associated with polymicrogyria without CFEOM.</p></div><div id="cfeom.Penetrance"><h3>Penetrance</h3><p>Penetrance in CFEOM1A, CFEOM1B, CFEOM2, CFEOM3B, CFEOM3C, and Tukel syndrome is complete.</p><p>Penetrance in CFEOM3A can be incomplete and is estimated to be 90% in families harboring the <a href="#cfeom.TUBB2B">c.784C&#x0003e;T</a> (<a href="#cfeom.TUBB2B">p.Arg262Cys</a>) substitution [<a class="bk_pop" href="#cfeom.REF.doherty.1999.1687">Doherty et al 1999</a>].</p></div><div id="cfeom.Nomenclature"><h3>Nomenclature</h3><p>Although long felt to result from primary fibrosis of the extraocular muscles, neuroanatomic [<a class="bk_pop" href="#cfeom.REF.engle.1997.314">Engle et al 1997</a>, <a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>], genetic [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>], and neuroimaging [<a class="bk_pop" href="#cfeom.REF.demer.2005.530">Demer et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.kim.2005.728">Kim &#x00026; Hwang 2005</a>, <a class="bk_pop" href="#cfeom.REF.bosley.2006.2363">Bosley et al 2006</a>, <a class="bk_pop" href="#cfeom.REF.lim.2007.1601">Lim et al 2007</a>, <a class="bk_pop" href="#cfeom.REF.wu.2009.971">Wu et al 2009</a>, <a class="bk_pop" href="#cfeom.REF.demer.2010.4600">Demer et al 2010</a>] findings suggest that the various forms of CFEOM result from abnormal development of ocular motor neurons and their processes.</p></div><div id="cfeom.Prevalence"><h3>Prevalence</h3><p>A minimum prevalence of CFEOM is 1:230,000 [<a class="bk_pop" href="#cfeom.REF.reck.1998.676">Reck et al 1998</a>].</p><p>CFEOM1 and CFEOM3 <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases have been identified worldwide.</p><p>The few individuals reported with CFEOM2 have been offspring of <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> unions within Saudi, Turkish, and Iranian families [<a class="bk_pop" href="#cfeom.REF.traboulsi.2004.237">Traboulsi &#x00026; Engle 2004</a>].</p></div></div><div id="cfeom.Genetically_Related_Allelic_Disord"><h2 id="_cfeom_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b><i>KIF21A</i>, <i>PHOX2A.</i></b> No phenotypes other than those discussed in this <i>GeneReview</i> are associated with pathogenic variants in <i>KIF21A</i> or <i>PHOX2A</i>.</p><p><b><i>TUBB3.</i></b> A distinct set of pathogenic variants in TUBB3 cause malformations of cortical development without CFEOM [<a class="bk_pop" href="#cfeom.REF.poirier.2010.4462">Poirier et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.bahibuisson.2014.1676">Bahi-Buisson et al 2014</a>, <a class="bk_pop" href="#cfeom.REF.falletbianco.2014.69">Fallet-Bianco et al 2014</a>, <a class="bk_pop" href="#cfeom.REF.oegema.2015.5313">Oegema et al 2015</a>]. Individuals with these variants have intellectual disability, motor delays, and malformations of cortical development associated with neuronal migration and differentiation defects and axonal guidance and tract organization impairment (in the absence of CFEOM). MRI revealed a common complex cortical dysgenesis that combined frontally predominant microgyria or gyral disorganization and simplification, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> and hypertropic basal ganglia with fusion between putamen and caudate nucleus, cerebellar vermian dysplasia, hypoplastic brain stem, and hypoplastic corpus callosum. Sequence analysis identified pathogenic variants in 6% (7/120) of individuals with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (6 novel pathogenic variants in 7 probands).</p><p>A subset of individuals with <i>TUBB3</i> pathogenic variants have facial weakness in addition to limited horizontal gaze; this can be confused with Moebius syndrome, but individuals with <i>TUBB3</i> variants have eyes fixed in abduction while those with Moebius syndrome have marked limitation of abduction [<a class="bk_pop" href="#cfeom.REF.mackinnon.2014.1461">MacKinnon et al 2014</a>].</p><p><b><i>TUBB2B.</i></b> Pathogenic variants in <i>TUBB2B</i> have been associated with microlissencephaly or polymicrogyria, usually accompanied by abnormalities of the corpus collosum and cerebellar, basal ganglia, and brain stem dysplasia, but without CFEOM [<a class="bk_pop" href="#cfeom.REF.jaglin.2009.746">Jaglin et al 2009</a>, <a class="bk_pop" href="#cfeom.REF.bahibuisson.2014.1676">Bahi-Buisson et al 2014</a>, <a class="bk_pop" href="#cfeom.REF.falletbianco.2014.69">Fallet-Bianco et al 2014</a>, <a class="bk_pop" href="#cfeom.REF.oegema.2015.5313">Oegema et al 2015</a>].</p></div><div id="cfeom.Differential_Diagnosis"><h2 id="_cfeom_Differential_Diagnosis_">Differential Diagnosis</h2><p>The term "<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cranial dysinnervation disorders (CCDDs)" was coined to refer to disorders of innervation of cranial musculature [<a class="bk_pop" href="#cfeom.REF.gutowski.2003.573">Gutowski et al 2003</a>]. The various forms of CFEOM are included in the CCDDs. Other CCDDs include Duane syndrome, Moebius syndrome, and congenital facial palsy.</p><p>The following conditions can be confused with CFEOM:</p><p><b>Brown syndrome</b> ("superior oblique tendon sheath syndrome") is characterized by the inability to elevate the adducted eye actively or passively. Most <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> Brown syndrome is <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family) and believed to result from anomalies of the tendon or the trochlear apparatus. Rare <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases have been reported [<a class="bk_pop" href="#cfeom.REF.iannaccone.2002.175">Iannaccone et al 2002</a>].</p><p><a href="/books/n/gene/duane/"><b>Duane syndrome</b></a> is characterized by horizontal eye movement limitation, narrowing of the palpebral fissure on attempted side gaze (usually adduction), and retraction of the globe on attempted adduction. It is believed to result from abnormal development of the abducens nucleus and nerve (cranial nerve VI).</p><p>Although the majority of cases of Duane syndrome are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> (i.e., not associated with other malformations), rare families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance of Duane syndrome with or without accompanying anomalies have been reported:</p><ul><li class="half_rhythm"><div class="half_rhythm">An <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for Duane syndrome was mapped by linkage analysis to 2q31 (DURS2, OMIM <a href="http://www.omim.org/entry/604356" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604356</a>). All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had bilateral Duane syndrome type 1 or type 3; the prevalence of manifest strabismus and amblyopia was high. Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes in <i>CHN1</i> that cosegregated with the affected haplotypes were identified [<a class="bk_pop" href="#cfeom.REF.miyake.2008.839">Miyake et al 2008</a>]. All were predicted to alter amino acids that were conserved in eight different species. <i>CHN1</i> was subsequently found not to be a common cause of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> Duane syndrome [<a class="bk_pop" href="#cfeom.REF.miyake.2010.215">Miyake et al 2010</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">A <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> with Duane syndrome is located on 8q13 (DURS1, OMIM <a href="http://www.omim.org/entry/126800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">126800</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/drrs/"><b><i>SALL4</i>-related disorders</b></a><b>.</b> The <i>SALL4</i>-related syndromes include Okihiro syndrome, Duane-radial ray syndrome, acro-renal-ocular syndrome, and IVIC syndrome. These overlapping syndromes are characterized by unilateral or bilateral Duane syndrome and radial ray malformations that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs; hypoplasia or aplasia of the radii; shortening and radial deviation of the forearms; triphalangeal thumbs; and duplication of the thumb (preaxial polydactyly). Deafness, renal anomalies, and imperforate anus can be coinherited. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div><div class="half_rhythm">Heterozygous <i>SALL4</i> pathogenic variants are associated with most <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases of these syndromes [<a class="bk_pop" href="#cfeom.REF.albaradie.2002.1195">Al-Baradie et al 2002</a>, <a class="bk_pop" href="#cfeom.REF.kohlhase.2002.2979">Kohlhase et al 2002</a>]. Individuals who represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> Duane syndrome have not been found to harbor pathogenic variants in <i>SALL4</i> [<a class="bk_pop" href="#cfeom.REF.wabbels.2004.216">Wabbels et al 2004</a>]. However, some members of families segregating a <i>SALL4-</i>related disorder have been found to harbor a <i>SALL4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and to manifest isolated Duane syndrome (without hand or other anomalies) [<a class="bk_pop" href="#cfeom.REF.albaradie.2002.1195">Al-Baradie et al 2002</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Athabaskan brain stem dysgenesis syndrome (ABDS) [<a class="bk_pop" href="#cfeom.REF.holve.2003.169">Holve et al 2003</a>] and Bosley-Salih-Alorainy syndrome (BSAS) [<a class="bk_pop" href="#cfeom.REF.tischfield.2005.1035">Tischfield et al 2005</a>] (OMIM <a href="http://www.omim.org/entry/601536" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601536</a>) are <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders that result from pathogenic variants in <i>HOXA1</i> [<a class="bk_pop" href="#cfeom.REF.tischfield.2005.1035">Tischfield et al 2005</a>]. They are characterized by Duane syndrome type III or horizontal gaze palsy and, in most individuals, bilateral sensorineural hearing loss caused by absent cochlea and rudimentary inner ear development. Depending on the specific syndrome (ABDS vs. BSAS), a subset of individuals manifests intellectual disability, autism, moderate to severe central hypoventilation, facial weakness, swallowing difficulties, vocal cord paresis, conotruncal heart defects, and skull and craniofacial abnormalities.</div></li></ul><p><b>Chronic progressive external ophthalmoplegia (CPEO)</b> is characterized by chronic progressive loss of extraocular eye movements and ptosis.</p><p><a href="/books/n/gene/kss/"><b>Mitochondrial DNA deletion syndromes</b></a> comprise three overlapping phenotypes, which may be observed in different members of the same family or may evolve in a given individual over time. The three phenotypes are: Kearns-Sayre syndrome (KSS), Pearson syndrome, and progressive external ophthalmoplegia (PEO). These syndromes are caused by mtDNA deletions ranging in size from two to ten kilobases.</p><ul><li class="half_rhythm"><div><b>KSS</b> is defined by the triad of onset before age 20 years, pigmentary retinopathy, and PEO. Individuals additionally have at least one of the following: cardiac conduction block, cerebrospinal fluid protein concentration greater than 100 mg/dL, or cerebellar ataxia. Approximately 90% of individuals with KSS have a large-scale (i.e., 1.3- to 10-kb) mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that is usually present in all tissues; however, mutated mtDNA is often undetectable in blood cells, necessitating examination of muscle.</div></li><li class="half_rhythm"><div><b>Pearson syndrome</b> is characterized by sideroblastic anemia and exocrine pancreas dysfunction. In Pearson syndrome, mtDNA deletions are usually more abundant in blood than in other tissues.</div></li><li class="half_rhythm"><div><b>PEO</b> is characterized by progressive ptosis, paralysis of the extraocular muscles (ophthalmoplegia), and variably severe proximal limb weakness.</div></li></ul><p>Other disorders associated with ophthalmoplegia include (with distinguishing features) the following:</p><ul><li class="half_rhythm"><div>Myasthenia gravis (fluctuating weakness and diplopia); see <a href="/books/n/gene/cms/">Congenital Myasthenic Syndromes</a>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/opmd/">Oculopharyngeal muscular dystrophy</a> (late-onset severe dysphagia, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance; caused by an expansion of a GCG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> of <i>PABPN1,</i> the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding polyadenylate binding protein nuclear 1)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/myotonic-d/">Myotonic dystrophy type 1</a> (myotonia, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance; caused by expansion of a CTG <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> in <i>DMPK</i>)</div></li><li class="half_rhythm"><div>Mendelian PEOs associated with multiple deletions of mtDNA caused by pathogenic variants in the nuclear genes <i>SLC25A4</i>, <i>PEO1</i>, <i>POLG</i>, and <i>TMPO</i> (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or recessive inheritance; affective disorders, gastrointestinal dysmotility); see <a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a>.</div></li><li class="half_rhythm"><div>Maternally inherited PEOs caused by various mtDNA pathogenic variants</div></li></ul><p><b>Cranial nerve III and IV palsy.</b> Few reports of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> third-nerve palsy or fourth-nerve palsy exist. The etiologies of these disorders are unknown.</p><p><b>Horizontal gaze palsy with progressive scoliosis (HGPPS)</b> (OMIM <a href="http://www.omim.org/entry/607313" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607313</a>) is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> horizontal gaze palsy (no horizontal eye movements) with progressive scoliosis inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner and caused by pathogenic variants in <i>ROBO3</i> [<a class="bk_pop" href="#cfeom.REF.jen.2004.1509">Jen et al 2004</a>]. Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>ROBO3</i> pathogenic variants have also been identified in children of non-<a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents [<a class="bk_pop" href="#cfeom.REF.chan.2006.e11">Chan et al 2006</a>]. Results of neuroimaging and neurophysiology studies undertaken on individuals with HGPPS found that the axons that make up the major motor and sensory pathways for communication between the brain and the body fail to cross the midline in the hindbrain [<a class="bk_pop" href="#cfeom.REF.jen.2004.1509">Jen et al 2004</a>, <a class="bk_pop" href="#cfeom.REF.bosley.2005.1196">Bosley et al 2005</a>].</p><p><b>Moebius syndrome (MBS)</b> (OMIM <a href="http://www.omim.org/entry/157900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">157900</a>) is characterized by facial weakness or diplegia with ocular abduction deficit.</p><ul><li class="half_rhythm"><div>The vast majority of individuals with Moebius syndrome represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases and many are associated with developmental defects of additional lower cranial nerves and distal extremities.</div></li><li class="half_rhythm"><div>Moebius sequence has also been reported in association with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> non-progressive myopathy and Robin sequence (OMIM <a href="http://www.omim.org/entry/254940" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">254940</a>)</div></li></ul><p><b>Hereditary <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> facial paresis,</b> the <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> dysfunction of the facial nerve, maps to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 3q (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> HCFP1) (OMIM <a href="http://www.omim.org/entry/601471" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601471</a>) and chromosome 10q (locus HCFP2) (OMIM <a href="http://www.omim.org/entry/604185" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604185</a>).</p><p><b>Other.</b> CFEOM has been identified in one individual with <a href="/books/n/gene/noonan/">Noonan syndrome</a> [<a class="bk_pop" href="#cfeom.REF.elgohary.2005.319">Elgohary et al 2005</a>].</p></div><div id="cfeom.Management"><h2 id="_cfeom_Management_">Management</h2><div id="cfeom.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> fibrosis of the extraocular muscles, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div><ul><li class="half_rhythm"><div>Determination of resting gaze position, head position with eyes in resting gaze position, and vertical and horizontal gaze restrictions</div></li><li class="half_rhythm"><div>Evaluation for aberrant movements including synergistic convergence and divergence, globe retraction, Marcus Gunn jaw wink</div></li><li class="half_rhythm"><div>Palpebral fissure size measurement</div></li><li class="half_rhythm"><div>Anterior segment evaluation to detect corneal exposure</div></li><li class="half_rhythm"><div>Levator function testing</div></li><li class="half_rhythm"><div>Optional forced duction testing</div></li><li class="half_rhythm"><div>Refraction, including cycloplegic refraction in children</div></li><li class="half_rhythm"><div>Photographic documentation for future comparison</div></li></ul></li><li class="half_rhythm"><div>Neuroimaging suggested if there are any additional neurologic symptoms or developmental delays</div></li><li class="half_rhythm"><div>Strongly recommended if eye muscle surgery is planned:</div><ul><li class="half_rhythm"><div>Brain and brain stem MRI scan to determine the size and/or course of the oculomotor and trochlear nerves</div></li><li class="half_rhythm"><div>High-resolution orbital MRI (1- to 3-mm cuts) to detect abnormalities in the size and/or course of the extraocular muscle(s) and atrophy of the superior rectus-levator complex</div></li></ul></li></ul></div><div id="cfeom.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Nonsurgical treatment</b> of ophthalmologic findings:</p><ul><li class="half_rhythm"><div>Refractive errors may be managed with spectacles or contact lenses. Specialist examination is required to detect refractive errors early in life, when <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be asymptomatic, to prevent amblyopia and avoid compounding the motility problem with a focusing problem.</div></li><li class="half_rhythm"><div>Amblyopia can be treated effectively with occlusion or penalization of the better-seeing eye. Early detection (in the first years of life) maximizes the likelihood of a good response to treatment.</div></li><li class="half_rhythm"><div>Lubrication of ocular surface (particularly cornea) may be required. In cases of severe exposure, a PROSE lens can be of significant benefit [<a class="bk_pop" href="#cfeom.REF.papakostas.2015.248">Papakostas et al 2015</a>].</div></li></ul><p><b>Surgical treatment</b> of ophthalmologic findings (extraocular muscle and/or ptosis surgery):</p><ul><li class="half_rhythm"><div>Correction of ptosis</div></li><li class="half_rhythm"><div>Eye muscle surgery</div><ul><li class="half_rhythm"><div>To correct or improve a compensatory head posture</div></li><li class="half_rhythm"><div>To improve alignment in primary gaze position</div></li><li class="half_rhythm"><div>To improve ambulation and gross motor development in young children</div></li></ul></li><li class="half_rhythm"><div>Principles of surgical approach:</div><ul><li class="half_rhythm"><div>Orbital imaging is recommended before surgery to assess muscle size and position.</div></li><li class="half_rhythm"><div>Extraocular muscles may be found at surgery to be attached in unexpected locations.</div></li><li class="half_rhythm"><div>Resections or plications may be helpful in some cases to provide traction against large recessions during healing.</div></li><li class="half_rhythm"><div>Surgery is likely to be technically difficult because of tightness of rectus muscles.</div></li><li class="half_rhythm"><div>Recessions need to be larger &#x02013; sometimes considerably larger &#x02013; than indicated by standard tables, especially recessions of the inferior rectus muscles.</div></li><li class="half_rhythm"><div>Dysinnervation causing esotropia in attempted upgaze may mask an underlying exotropia that will be unmasked after inferior rectus muscle weakening.</div></li><li class="half_rhythm"><div>Inferior rectus muscle weakening may be enhanced by superior oblique weakening.</div></li><li class="half_rhythm"><div>Profound weakening procedures (e.g., suturing muscle to orbital rim, rectus muscle myectomy) may be necessary.</div></li><li class="half_rhythm"><div>Botulinum toxin may be helpful for residual misalignment in some cases.</div></li></ul></li></ul></div><div id="cfeom.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Amblyopia therapy to prevent vision loss in the less-preferred eye</div></li><li class="half_rhythm"><div>Eye lubrication to avoid dry eyes, particularly following ptosis surgery but also after successful strabismus surgery in some cases</div></li><li class="half_rhythm"><div>Surgical repositioning of the eyes and lids to help correct head position and alleviate secondary musculoskeletal complications from chronic head turn</div></li></ul></div><div id="cfeom.Surveillance"><h3>Surveillance</h3><p>CFEOM is <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and is believed to be non-progressive.</p><p>Surveillance is important for prevention of amblyopia, and to treat amblyopia and complications of corneal exposure [<a class="bk_pop" href="#cfeom.REF.yazdani.2004.1035">Yazdani &#x00026; Traboulsi 2004</a>].</p><p>Routine ophthalmologic care is indicated, with visits every three to four months during the first years of life, and annual or biannual examinations in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals not at risk for amblyopia.</p><p>In individuals with specific <i>TUBB3</i> variants, surveillance for endocrine abnormalities, facial or vocal cord weakness, and interventions for developmental delays are indicated.</p></div><div id="cfeom.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are not known, clinical ophthalmologic exam can be used to clarify the disease status of at-risk relatives.</div></li></ul><p>See <a href="#cfeom.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cfeom.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cfeom.Genetic_Counseling"><h2 id="_cfeom_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cfeom.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Congenital fibrosis of the extraocular muscles (CFEOM) 1 (mutation of <i>KIF21A</i> or <i>TUBB3</i>), CFEOM3 (mutation of <i>TUBB3</i>, <i>TUBB2B</i>, or <i>KIF21A</i>), and CFEOM3 with polymicrogyria (mutation of <i>TUBB2B</i>) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>CFEOM2 (mutation of <i>PHOX2A</i>) and Tukel syndrome (molecular basis unknown) are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><div id="cfeom.Risk_to_Family_Members__Autosomal"><h4>Risk to Family Members &#x02013; Autosomal Dominant Inheritance (CFEOM1, CFEOM3, CFEOM3 with Polymicrogyria)</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KIF21A</i>, <i>TUBB3</i>, or <i>TUBB2B</i>.</div><ul><li class="half_rhythm"><div><b><i>KIF21A</i>.</b>
<i>De novo</i> pathogenic variants have been reported (see <a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al [2003]</a>).</div></li><li class="half_rhythm"><div><b><i>TUBB3</i>.</b> The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> among patients with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> CFEOM3 (no other neurologic deficits) has been reported to be 25% (4/16 pedigrees) [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>]. Probands with CFEOM3A with additional neurological deficits are usually the result of <i>de novo</i>
<i>TUBB3</i> pathogenic variant (85%, 17/20 pedigrees) [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.chew.2013.522">Chew et al 2013</a>, <a class="bk_pop" href="#cfeom.REF.balasubramanian.2015.e473">Balasubramanian et al 2015</a>, <a class="bk_pop" href="#cfeom.REF.whitman.2016.297">Whitman et al 2016</a>].</div></li><li class="half_rhythm"><div><b><i>TUBB2B</i>.</b> The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TUBB2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown.</div></li></ul></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KIF21A</i>, <i>TUBB3</i>, or <i>TUBB2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include ophthalmologic examinations and consideration of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the pathogenic variant if one has been identified in the proband.</div></li><li class="half_rhythm"><div>If a <i>KIF21A</i>, <i>TUBB3</i>, or <i>TUBB2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div><ul><li class="half_rhythm"><div><b><i>KIF21A</i>.</b> Two families with parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported [<a class="bk_pop" href="#cfeom.REF.liu.2014.15">Liu et al 2014</a>].</div></li><li class="half_rhythm"><div><b><i>TUBB3.</i></b> Two families with presumed parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>].</div></li><li class="half_rhythm"><div><b><i>TUBB2B.</i></b> No cases of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported.</div></li></ul></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria may appear to be negative because of failure to recognize the disorder in family members or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., ocular examination and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent has clinical characteristics consistent with CFEOM and/or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KIF21A</i>, <i>TUBB3</i>, or <i>TUBB2B</i>, the risk to the sibs is 50%. The chance that a sib who inherits the pathogenic variant will manifest CFEOM may be less than 50% depending on the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the variant (see <a href="#cfeom.Penetrance">Penetrance</a>).</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for CFEOM because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with CFEOM1, CFEOM3, or CFEOM3 with polymicrogyria has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="cfeom.Risk_to_Family_Members__Autosomal_1"><h4>Risk to Family Members &#x02013; Autosomal Recessive Inheritance (CFEOM2 and Tukel Syndrome)</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an individual with CFEOM2 or Tukel syndrome are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li><li class="half_rhythm"><div>Pseudodominant inheritance (i.e., an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> condition present in individuals in two or more generations) of CFEOM2 has been reported in two <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families [<a class="bk_pop" href="#cfeom.REF.wang.1998.517">Wang et al 1998</a>] (see <a href="#cfeom.Prevalence">Prevalence</a>). Two-generation involvement can occur in autosomal recessive disorders when a parent (who has 2 pathogenic alleles) is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and his/her reproductive partner is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an individual with CFEOM2 or Tukel syndrome has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with CFEOM2 or Tukel syndrome are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></div><div id="cfeom.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p><b>CFEOM2.</b> Carrier testing for relatives at risk requires prior identification of the <i>PHOX2A</i> pathogenic variants in the family.</p><p><b>Tukel syndrome.</b> Carrier testing using molecular genetic techniques is not possible because the associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has not been identified.</p></div><div id="cfeom.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cfeom.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cfeom.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>KIF21A</i>, <i>TUBB3</i>, <i>TUBB2B</i>, or <i>PHOX2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CFEOM are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cfeom.Resources"><h2 id="_cfeom_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://nei.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">https://nei.nih.gov/</a></div></li><li class="half_rhythm"><div><b>Prevent Blindness America</b></div><div>211 West Wacker Drive</div><div>Suite 1700</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-331-2020 (toll-free)</div><div><b>Email:</b> info@preventblindness.org</div><div><a href="http://www.preventblindness.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.preventblindness.org</a></div></li><li class="half_rhythm"><div><b>eyeGENE - National Ophthalmic Disease Genotyping Network Registry</b></div><div><b>Phone:</b> 301-435-3032</div><div><b>Email:</b> eyeGENEinfo@nei.nih.gov</div><div><a href="https://eyegene.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nei.nih.gov/eyegene</a></div></li></ul></div><div id="cfeom.Molecular_Genetics"><h2 id="_cfeom_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cfeom.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Congenital Fibrosis of the Extraocular Muscles: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FEOM1</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55605" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KIF21A</i></a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55605" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q12</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z4S6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Kinesin-like protein KIF21A</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KIF21A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KIF21A</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KIF21A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KIF21A</a></td></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FEOM2</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/401" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PHOX2A</i></a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=401" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.4</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14813" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Paired mesoderm homeobox protein 2A</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PHOX2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PHOX2A database</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PHOX2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PHOX2A</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PHOX2A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PHOX2A</a></td></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FEOM3</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10381" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TUBB3</i></a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10381" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13509" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tubulin beta-3 chain</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TUBB3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TUBB3</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TUBB3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TUBB3</a></td></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">FEOM4</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">13q12.11</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">TUKLS</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">21q22</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_b_cfeom.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/347733" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TUBB2B</i></a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=347733" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p25<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BVA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tubulin beta-2B chain</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TUBB2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TUBB2B database</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TUBB2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TUBB2B</a></td><td headers="hd_b_cfeom.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TUBB2B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TUBB2B</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cfeom.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cfeom.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Congenital Fibrosis of the Extraocular Muscles (<a href="/omim/135700,600638,602078,602661,602753,608283,609384,609428,610031,612850" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/135700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">135700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600638" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600638</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602078" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602078</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602661" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602661</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TUBULIN, BETA-3; TUBB3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602753" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602753</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PAIRED-LIKE HOMEOBOX 2A; PHOX2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608283" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608283</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KINESIN FAMILY MEMBER 21A; KIF21A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609384" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609384</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609428" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609428</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TUKEL SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610031" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610031</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612850" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612850</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TUBULIN, BETA-2B; TUBB2B</td></tr></tbody></table></div></div><div id="cfeom.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>CFEOM is a cranial motor neuron disorder caused by pathogenic variants in the genes encoding KIF21A, PHOX2A, TUBB3, and TUBB2B. These proteins are expressed in tissues <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> in CFEOM, as well as many other tissues. KIF21A is expressed widely in the cell bodies, axons and dendrites of multiple neuronal populations, as well as extraocular and other skeletal muscles [<a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.desai.2012.180">Desai et al 2012</a>]. TUBB3 is expressed primarily in neurons [<a class="bk_pop" href="#cfeom.REF.katsetos.2003.851">Katsetos et al 2003</a>]. TUBB2B is highly expressed in both neurons and glia.</p><p>Microtubules are copolymers assembled from tubulin heterodimers, which contain several different alpha- and &#x003b2;-tubulin isotypes encoded by separate genes. KIF21A, a member of the kinesin family of molecular motors, interacts with the microtubule track to transport cargos in an anterograde direction from the cell body to the developing growth cone [<a class="bk_pop" href="#cfeom.REF.marszalek.1999.469">Marszalek et al 1999</a>]. TUBB3 and TUBB2B are components of the microtubules. PHOX2A is a homeodomain <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> protein that plays a primary role in the oculomotor and trochlear alpha motor neuron development in mice and zebrafish [<a class="bk_pop" href="#cfeom.REF.pattyn.1997.4065">Pattyn et al 1997</a>, <a class="bk_pop" href="#cfeom.REF.guo.1999.555">Guo et al 1999</a>].</p><div id="cfeom.KIF21A"><h4><i>KIF21A</i></h4><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 5,022 bp in 38 exons with alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 12 and exons 29-31. Genomic length is approximately 150 kb [<a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>]. Alternative splicing results in cDNAs of varying lengths. Reference sequence <a href="/nuccore/NM_001173464.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001173464.1</a> (<a class="figpopup" href="/books/NBK1348/table/cfeom.T.selected_kif21a_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcfeomTselectedkif21apathogenicvaria" rid-ob="figobcfeomTselectedkif21apathogenicvaria">Table 3</a>) is the longest transcript variant. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1348/#cfeom.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Ten <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>KIF21A</i> variants have been associated with CFEOM1 [<a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>, <a class="bk_pop" href="#cfeom.REF.ali.2004.247">Ali et al 2004</a>, <a class="bk_pop" href="#cfeom.REF.tiab.2004.241">Tiab et al 2004</a>, <a class="bk_pop" href="#cfeom.REF.lin.2005.245">Lin et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.shimizu.2005.443">Shimizu et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.chan.2007.26">Chan et al 2007</a>, <a class="bk_pop" href="#cfeom.REF.lu.2008.388">Lu et al 2008</a>, <a class="bk_pop" href="#cfeom.REF.rudolph.2009.667">Rudolph et al 2009</a>, <a class="bk_pop" href="#cfeom.REF.khan.2010.154">Khan et al 2010</a>] and CFEOM3 [<a class="bk_pop" href="#cfeom.REF.yamada.2004.2218">Yamada et al 2004</a>, <a class="bk_pop" href="#cfeom.REF.lin.2005.245">Lin et al 2005</a>, <a class="bk_pop" href="#cfeom.REF.lu.2008.388">Lu et al 2008</a>, <a class="bk_pop" href="#cfeom.REF.yang.2010.2062">Yang et al 2010</a>]. One missense variant was identified in one CFEOM3 <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> [<a class="bk_pop" href="#cfeom.REF.yamada.2004.2218">Yamada et al 2004</a>].</p><p>In a study of 127 probands, the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.2860C&#x0003e;T accounted for more than 40% of abnormal alleles. Seven of these <i>KIF21A</i> pathogenic variants occur at only three amino-acid residues, each located in the "a" position of a heptad repeat within an alpha helical coiled-coil region of the KIF21A stalk. The c.84C&#x0003e;G and c.1067T&#x0003e;C pathogenic variants are located in the motor <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Haplotype analysis demonstrated that five <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants found in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CFEOM1 pedigrees all arose exclusively on the paternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#cfeom.REF.yamada.2003.318">Yamada et al 2003</a>].</p><div id="cfeom.T.selected_kif21a_pathogenic_varia" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>KIF21A</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.T.selected_kif21a_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.T.selected_kif21a_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.84C&#x0003e;G</td><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys28Trp</td><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001173464.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001173464<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001166935.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001166935<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1067T&#x0003e;C</td><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met356Thr</td></tr><tr><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2860C&#x0003e;T</td><td headers="hd_h_cfeom.T.selected_kif21a_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg954Trp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The predicted protein, encoded by transcript <a href="/nuccore/NM_001173464.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001173464.1</a>, kinesin family member 21A (KIF21A), is 1674 amino acids and comprises three domains characteristic of the kinesin superfamily: an N-terminal motor <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that interacts with the microtubule track, a central coiled-coil stalk, and a C-terminal tail that loads or interacts with transported cargo [<a class="bk_pop" href="#cfeom.REF.marszalek.1999.469">Marszalek et al 1999</a>]. See <a href="#cfeom.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>.</p><p>Kif21a <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> and protein are expressed early during mouse development highly in the brain and moderately in the kidney, testes, and skeletal muscle [<a class="bk_pop" href="#cfeom.REF.marszalek.1999.469">Marszalek et al 1999</a>]. Kif21a is hypothesized to interact with the insoluble cytoskeleton or a large protein complex [<a class="bk_pop" href="#cfeom.REF.marszalek.1999.469">Marszalek et al 1999</a>]. In vitro, KIF21A acts as an inhibitor of microtubule dynamics [<a class="bk_pop" href="#cfeom.REF.van_der_vaart.2013.145">van der Vaart et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In vivo and in vitro, CFEOM-causing pathogenic variants in <i>KIF21A</i> attenuate normal autoinhibition of the protein, leading to a constitutively active molecule, increased microtubule association, and oculomotor axon stalling [<a class="bk_pop" href="#cfeom.REF.cheng.2014.334">Cheng et al 2014</a>].</p></div><div id="cfeom.PHOX2A"><h4><i>PHOX2A</i></h4><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> contains three exons. The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> length is approximately 5 kb [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>]. For a detailed summary of gene and protein information, see <a href="/books/NBK1348/#cfeom.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Four different <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <i>PHOX2A</i> pathogenic variants have been identified in five families with CFEOM2. Two pathogenic variants are single-base substitutions (1 <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and 1 <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>) and two are splice-site variants [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.yazdani.2003.861">Yazdani et al 2003</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene product is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> protein containing a homeodomain and brachyury-like motif. See <a href="#cfeom.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</a>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> It is predicted that most pathogenic variants in <i>PHOX2A</i> lead to the truncation of the protein resulting in complete loss of protein function [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>, <a class="bk_pop" href="#cfeom.REF.bosley.2006.2363">Bosley et al 2006</a>]. It is predicted that CFEOM2 results from aberrant development of the motor nuclei [<a class="bk_pop" href="#cfeom.REF.nakano.2001.315">Nakano et al 2001</a>].</p><p><a class="bk_pop" href="#cfeom.REF.morin.1997.411">Morin et al [1997]</a> demonstrated that <i>Phox2a</i>
<sup>-/-</sup> mice completely lacked a <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> coeruleus, the main noradrenergic center of the brain. Furthermore, parasympathetic ganglia in the head are missing, and the superior cervical ganglion, as well as cranial sensory ganglia that normally express <i>Phox2a</i>, are severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. <a class="bk_pop" href="#cfeom.REF.pattyn.1997.4065">Pattyn et al [1997]</a> demonstrated that these mice also completely lack oculomotor and trochlear motor neurons.</p></div><div id="cfeom.TUBB3"><h4><i>TUBB3</i></h4><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> (<a href="/nuccore/NM_006086.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006086.3</a>, transcript variant 1) comprises 1794 bp in four exons and encodes 450 amino acids. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1348/#cfeom.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Ten <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants causative of CFEOM3A alter eight amino acids in exons 3 and 4 and occur recurrently [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.whitman.2016.297">Whitman et al 2016</a>]. Thirty-two percent of 34 reported probands have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.784C&#x0003e;T (p.Arg262Cys). CFEOM1B is most frequently caused by the missense variants c.784C&#x0003e;T (p.Arg262Cys) or c.1249G&#x0003e;A (p.Asp417Asn).</p><div id="cfeom.T.selected_tubb3_pathogenic_varian" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>TUBB3</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.T.selected_tubb3_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.T.selected_tubb3_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.185G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg62Gln</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_3" rowspan="10" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_006086.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006086<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_006077.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006077<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.211G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly91Arg</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.292G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly98Ser</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.784C&#x0003e;T</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg262Cys</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.785G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg262His</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.904G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala302Thr</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1138C&#x0003e;T</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg380Cys</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1228G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu410Lys</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1249G&#x0003e;A</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp417Asn</td></tr><tr><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1249G&#x0003e;C</td><td headers="hd_h_cfeom.T.selected_tubb3_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp417His</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> This gene encodes a class III member of the beta tubulin protein family. Tubulin is the major constituent of microtubules. The TUBB3 protein is expressed in neurons and thought to be involved in neurogenesis and in axon guidance and maintenance.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Multiple clinical findings and the recurrence of <i>TUBB3</i> pathogenic variants suggest that the pathogenic variants underlying CFEOM3 primarily alter microtubule function in a dominant fashion [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>]. CFEOM-causing pathogenic vairants have been associated with increased microtubule stability [<a class="bk_pop" href="#cfeom.REF.tischfield.2010.74">Tischfield et al 2010</a>, <a class="bk_pop" href="#cfeom.REF.tischfield.2011.286">Tischfield et al 2011</a>].</p></div><div id="cfeom.TUBB2B"><h4><i>TUBB2B</i></h4><p><b>Gene structure.</b> The normal <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> comprises 2019 bp in four exons and encodes 445 amino acids. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1348/#cfeom.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Seven <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variants are associated with polymicrogyria. One heterozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, p.Glu421Lys, is associated with CFEOM3 with polymicrogyria.</p><div id="cfeom.T.tubb2b_pathogenic_variants_discu" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>TUBB2B</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1348/table/cfeom.T.tubb2b_pathogenic_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cfeom.T.tubb2b_pathogenic_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1261G&#x0003e;A</td><td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu421Lys</td><td headers="hd_h_cfeom.T.tubb2b_pathogenic_variants_discu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_006086.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_178012<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_821080.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_821080<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 445-amino acid protein has an N-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, an intermediate domain, and a C-terminal domain. This gene encodes a class II member of the beta tubulin protein family, beta-tubulin isotype IIB (TUBB2B). Tubulin is the major constituent of microtubules. The TUBB2B protein is expressed in neurons and glia in the central and peripheral nervous system.</p><p>Several pathogenic variants in humans lead to polymicrogyria, and are associated with decreased levels of TUBB2B protein. The p.Glu421Lys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, which is associated with CFEOM3 with polymicrogyria, causes increased microtubule stability in yeast and disrupts kinesin binding sites [<a class="bk_pop" href="#cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants associated with polymicrogyria fold and incorporate into microtubules poorly, and the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may therefore be caused by <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with CFEOM3 with polymicrogyria reduces the formation of alpha-beta heterodimers, and disrupts microtubule dynamics [<a class="bk_pop" href="#cfeom.REF.cederquist.2012.5484">Cederquist et al 2012</a>].</p></div></div></div><div id="cfeom.References"><h2 id="_cfeom_References_">References</h2><div id="cfeom.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.albaradie.2002.1195">Al-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, McIntosh N, Nakano M, Martonyi EJ, Raymond WR, Okumura S, Okihiro MM, Engle EC. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1195–9.</span> [<a href="/pmc/articles/PMC385096/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC385096</span></a>] [<a href="/pubmed/12395297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12395297</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.ali.2004.247">Ali M, Venkatesh C, Ragunath A, Kumar A. Mutation analysis of the KIF21A gene in an Indian family with CFEOM1: implication of CpG methylation for most frequent mutations. <span><span class="ref-journal">Ophthalmic Genet. </span>2004;<span class="ref-vol">25</span>:247–55.</span> [<a href="/pubmed/15621877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15621877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.ali.2014.368">Ali Z, Xing C, Anwar D, Itani K, Weakley D, Gong X, Pascual JM, Mootha VV. A novel de novo KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and M&#x000f6;bius syndrome. <span><span class="ref-journal">Mol Vis. </span>2014;<span class="ref-vol">20</span>:368–75.</span> [<a href="/pmc/articles/PMC3976685/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3976685</span></a>] [<a href="/pubmed/24715754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24715754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.aubourg.2005.253">Aubourg P, Krahn M, Bernard R, Nguyen K, Forzano O, Boccaccio I, Delague V, De Sandre-Giovannoli A, Pouget J, Depetris D, Mattei MG, Philip N, Levy N. Assignment of a new congenital fibrosis of extraocular muscles type 3 (CFEOM3) locus, FEOM4, based on a balanced translocation t(2;13) (q37.3;q12.11) and identification of candidate genes. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:253–9.</span> [<a href="/pmc/articles/PMC1736008/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736008</span></a>] [<a href="/pubmed/15744040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15744040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.bahibuisson.2014.1676">Bahi-Buisson N, Poirier K, Fourniol F, Saillour Y, Valence S, Lebrun N, Hully M, Bianco CF, Boddaert N, Elie C, Lascelles K, Souville I., LIS-Tubulinopathies Consortium.  Beldjord C, Chelly J. The wide spectrum of tubulinopathies: what are the key features for the diagnosis? <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:1676–700.</span> [<a href="/pubmed/24860126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24860126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.balasubramanian.2015.e473">Balasubramanian R, Chew S, MacKinnon SE, Kang PB, Andrews C, Chan WM, Engle EC. Expanding the phenotypic spectrum and variability of endocrine abnormalities associated with TUBB3 E410K syndrome. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2015;<span class="ref-vol">100</span>:E473–7.</span> [<a href="/pmc/articles/PMC4333039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4333039</span></a>] [<a href="/pubmed/25559402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25559402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.bosley.2006.2363">Bosley TM, Oystreck DT, Robertson RL, al Awad A, Abu-Amero K, Engle EC. Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in PHOX2A. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2363–74.</span> [<a href="/pubmed/16815872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16815872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.bosley.2005.1196">Bosley TM, Salih MA, Jen JC, Lin DD, Oystreck D, Abu-Amero KK, MacDonald DB, al Zayed Z, al Dhalaan H, Kansu T, Stigsby B, Baloh RW. Neurologic features of horizontal gaze palsy and progressive scoliosis with mutations in ROBO3. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1196–203.</span> [<a href="/pubmed/15824346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15824346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.brodsky.1998.717">Brodsky MC. Hereditary external ophthalmoplegia synergistic divergence, jaw winking, and oculocutaneous hypopigmentation: a congenital fibrosis syndrome caused by deficient innervation to extraocular muscles. <span><span class="ref-journal">Ophthalmology. </span>1998;<span class="ref-vol">105</span>:717–25.</span> [<a href="/pubmed/9544647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9544647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.cederquist.2012.5484">Cederquist GY, Luchniak A, Tischfield MA, Peeva M, Song Y, Menezes MP, Chan WM, Andrews C, Chew S, Jamieson RV, Gomes L, Flaherty M, Grant PE, Gupta ML Jr, Engle EC. An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:5484–99.</span> [<a href="/pmc/articles/PMC3516133/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3516133</span></a>] [<a href="/pubmed/23001566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23001566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.chan.2007.26">Chan WM, Andrews C, Dragan L, Fredrick D, Armstrong L, Lyons C, Geraghty MT, Hunter DG, Yazdani A, Traboulsi EI, Pott JW, Gutowski NJ, Ellard S, Young E, Hanisch F, Koc F, Schnall B, Engle EC. Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1. <span><span class="ref-journal">BMC Genet. </span>2007;<span class="ref-vol">8</span>:26.</span> [<a href="/pmc/articles/PMC1888713/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1888713</span></a>] [<a href="/pubmed/17511870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17511870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.chan.2006.e11">Chan WM, Traboulsi EI, Arthur B, Friedman N, Andrews C, Engle EC. Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:e11.</span> [<a href="/pmc/articles/PMC2563249/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563249</span></a>] [<a href="/pubmed/16525029" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16525029</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.cheng.2014.334">Cheng L, Desai J, Miranda CJ, Duncan JS, Qiu W, Nugent AA, Kolpak AL, Wu CC, Drokhlyansky E, Delisle MM, Chan WM, Wei Y, Propst F, Reck-Peterson SL, Fritzsch B, Engle EC. Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling. <span><span class="ref-journal">Neuron. </span>2014;<span class="ref-vol">82</span>:334–49.</span> [<a href="/pmc/articles/PMC4002761/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4002761</span></a>] [<a href="/pubmed/24656932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24656932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.chew.2013.522">Chew S, Balasubramanian R, Chan WM, Kang PB, Andrews C, Webb BD, MacKinnon SE, Oystreck DT, Rankin J, Crawford TO, Geraghty M, Pomeroy SL, Crowley WF Jr, Jabs EW, Hunter DG, Grant PE, Engle EC. A novel syndrome caused by the E410K amino acid substitution in the neuronal &#x003b2;-tubulin isotype 3. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:522–35.</span> [<a href="/pmc/articles/PMC3572929/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3572929</span></a>] [<a href="/pubmed/23378218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23378218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.demer.2005.530">Demer JL, Clark RA, Engle EC. Magnetic resonance imaging evidence for widespread orbital dysinnervation in congenital fibrosis of extraocular muscles due to mutations in KIF21A. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:530–9.</span> [<a href="/pubmed/15671279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15671279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.demer.2010.4600">Demer JL, Clark RA, Tischfield MA, Engle EC. Evidence of an asymmetrical endophenotype in congenital fibrosis of extraocular muscles type 3 resulting from TUBB3 mutations. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2010;<span class="ref-vol">51</span>:4600–11.</span> [<a href="/pmc/articles/PMC2941178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2941178</span></a>] [<a href="/pubmed/20393110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20393110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.desai.2012.180">Desai J, Velo MP, Yamada K, Overman LM, Engle EC. Spatiotemporal expression pattern of KIF21A during normal embryonic development and in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). <span><span class="ref-journal">Gene Expr Patterns. </span>2012;<span class="ref-vol">12</span>:180–8.</span> [<a href="/pmc/articles/PMC3358471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3358471</span></a>] [<a href="/pubmed/22465342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22465342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.doherty.1999.1687">Doherty EJ, Macy ME, Wang SM, Dykeman CP, Melanson MT, Engle EC. CFEOM3: a new extraocular congenital fibrosis syndrome that maps to 16q24.2-q24.3. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>1999;<span class="ref-vol">40</span>:1687–94.</span> [<a href="/pubmed/10393037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10393037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.elgohary.2005.319">Elgohary MA, Bradshaw P, Ahmad N. Anterior uveitis and congenital fibrosis of the extraocular muscles in a patient with Noonan syndrome. <span><span class="ref-journal">J Postgrad Med. </span>2005;<span class="ref-vol">51</span>:319–21.</span> [<a href="/pubmed/16388177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16388177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.engle.1997.314">Engle EC, Goumnerov BC, McKeown CA, Schatz M, Johns DR, Porter JD, Beggs AH. Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Ann Neurol. </span>1997;<span class="ref-vol">41</span>:314–25.</span> [<a href="/pubmed/9066352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9066352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.falletbianco.2014.69">Fallet-Bianco C, Laquerri&#x000e8;re A, Poirier K, Razavi F, Guimiot F, Dias P, Loeuillet L, Lascelles K, Beldjord C, Carion N, Toussaint A, Revencu N, Addor MC, Lhermitte B, Gonzales M, Martinovich J, Bessieres B, Marcy-Bonni&#x000e8;re M, Jossic F, Marcorelles P, Loget P, Chelly J, Bahi-Buisson N. Mutations in tubulin genes are frequent causes of various foetal malformations of cortical development including microlissencephaly. <span><span class="ref-journal">Acta Neuropathol Commun. </span>2014;<span class="ref-vol">2</span>:69.</span> [<a href="/pmc/articles/PMC4222268/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4222268</span></a>] [<a href="/pubmed/25059107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25059107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.flaherty.2001.1313">Flaherty MP, Grattan-Smith P, Steinberg A, Jamieson R, Engle EC. Congenital fibrosis of the extraocular muscles associated with cortical dysplasia and maldevelopment of the basal ganglia. <span><span class="ref-journal">Ophthalmology. </span>2001;<span class="ref-vol">108</span>:1313–22.</span> [<a href="/pubmed/11425694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11425694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.guo.1999.555">Guo S, Brush J, Teraoka H, Goddard A, Wilson SW, Mullins MC, Rosenthal A. Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/Phox2a. <span><span class="ref-journal">Neuron. </span>1999;<span class="ref-vol">24</span>:555–66.</span> [<a href="/pubmed/10595509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10595509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.gutowski.2003.573">Gutowski NJ, Bosley TM, Engle EC. 110th ENMC International Workshop: the congenital cranial dysinnervation disorders (CCDDs). Naarden, The Netherlands, 25-27 October, 2002. <span><span class="ref-journal">Neuromuscul Disord. </span>2003;<span class="ref-vol">13</span>:573–8.</span> [<a href="/pubmed/12921795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12921795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.harissidagher.2004.540">Harissi-Dagher M, Dagher JH, Aroichane M. Congenital fibrosis of the extraocular muscles with brain-stem abnormalities: a novel finding. <span><span class="ref-journal">Can J Ophthalmol. </span>2004;<span class="ref-vol">39</span>:540–5.</span> [<a href="/pubmed/15491041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15491041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.holve.2003.169">Holve S, Friedman B, Hoyme HE, Tarby TJ, Johnstone SJ, Erickson RP, Clericuzio CL, Cunniff C. Athabascan brainstem dysgenesis syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">120A</span>:169–73.</span> [<a href="/pubmed/12833395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12833395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.iannaccone.2002.175">Iannaccone A, McIntosh N, Ciccarelli ML, Baldi A, Mutolo PA, Tedesco SA, Engle EC. Familial unilateral Brown syndrome. <span><span class="ref-journal">Ophthalmic Genet. </span>2002;<span class="ref-vol">23</span>:175–84.</span> [<a href="/pubmed/12324876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12324876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.jaglin.2009.746">Jaglin XH, Poirier K, Saillour Y, Buhler E, Tian G, Bahi-Buisson N, Fallet-Bianco C, Phan-Dinh-Tuy F, Kong XP, Bomont P, Castelnau-Ptakhine L, Odent S, Loget P, Kossorotoff M, Snoeck I, Plessis G, Parent P, Beldjord C, Cardoso C, Represa A, Flint J, Keays DA, Cowan NJ, Chelly J. Mutations in the beta-tubulin gene TUBB2B result in asymmetrical polymicrogyria. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:746–52.</span> [<a href="/pmc/articles/PMC2883584/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2883584</span></a>] [<a href="/pubmed/19465910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19465910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.jen.2004.1509">Jen JC, Chan WM, Bosley TM, Wan J, Carr JR, Rub U, Shattuck D, Salamon G, Kudo LC, Ou J, Lin DD, Salih MA, Kansu T, Al Dhalaan H, Al Zayed Z, MacDonald DB, Stigsby B, Plaitakis A, Dretakis EK, Gottlob I, Pieh C, Traboulsi EI, Wang Q, Wang L, Andrews C, Yamada K, Demer JL, Karim S, Alger JR, Geschwind DH, Deller T, Sicotte NL, Nelson SF, Baloh RW, Engle EC. Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">304</span>:1509–13.</span> [<a href="/pmc/articles/PMC1618874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1618874</span></a>] [<a href="/pubmed/15105459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15105459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.ka_ar_bayram.2015.743">Ka&#x000e7;ar Bayram A, Per H, Quon J, Canpolat M, &#x000dc;lgen E, Do&#x0011f;an H, Gumus H, Kumandas S, Bayram N, Bilguvar K, &#x000c7;a&#x0011f;layan AO. A rare case of congenital fibrosis of extraocular muscle type 1A due to KIF21A mutation with Marcus Gunn jaw-winking phenomenon. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2015;<span class="ref-vol">19</span>:743–6.</span> [<a href="/pubmed/26190014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26190014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.karadeniz.2009.e570">Karadeniz N, Erkek E, Taner P. Unexpected clinical involvement of hereditary total leuconychia with congenital fibrosis of the extraocular muscles in three generations. <span><span class="ref-journal">Clin Exp Dermatol. </span>2009;<span class="ref-vol">34</span>:e570–2.</span> [<a href="/pubmed/19489868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19489868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.katsetos.2003.851">Katsetos CD, Legido A, Perentes E, M&#x000f6;rk SJ. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology. <span><span class="ref-journal">J Child Neurol. </span>2003;<span class="ref-vol">18</span>:851–66.</span> [<a href="/pubmed/14736079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14736079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.khan.2010.154">Khan AO, Khalil DS, Al Sharif LJ, Al-Ghadhfan FE, Al Tassan NA. Germline mosaicism for KIF21A mutation (p.R954L) mimicking recessive inheritance for congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Ophthalmology. </span>2010;<span class="ref-vol">117</span>:154–8.</span> [<a href="/pubmed/19896199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19896199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.khan.2011.218">Khan AO, Shinwari J, Omar A, Al-Sharif L, Khalil DS, Alanazi M, Al-Amri A, Al Tassan N. Lack of KIF21A mutations in congenital fibrosis of the extraocular muscles type I patients from consanguineous Saudi Arabian families. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:218–24.</span> [<a href="/pmc/articles/PMC3025099/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3025099</span></a>] [<a href="/pubmed/21264235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21264235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.kim.2005.728">Kim JH, Hwang JM. Hypoplastic oculomotor nerve and absent abducens nerve in congenital fibrosis syndrome and synergistic divergence with magnetic resonance imaging. <span><span class="ref-journal">Ophthalmology. </span>2005;<span class="ref-vol">112</span>:728–32.</span> [<a href="/pubmed/15808269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15808269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.kohlhase.2002.2979">Kohlhase J, Heinrich M, Schubert L, Liebers M, Kispert A, Laccone F, Turnpenny P, Winter RM, Reardon W. Okihiro syndrome is caused by SALL4 mutations. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:2979–87.</span> [<a href="/pubmed/12393809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12393809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.lim.2007.1601">Lim KH, Engle EC, Demer JL. Abnormalities of the oculomotor nerve in congenital fibrosis of the extraocular muscles and congenital oculomotor palsy. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2007;<span class="ref-vol">48</span>:1601–6.</span> [<a href="/pmc/articles/PMC2262868/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2262868</span></a>] [<a href="/pubmed/17389489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17389489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.lin.2005.245">Lin LK, Chien YH, Wu JY, Wang AH, Chiang SC, Hwu WL. KIF21A gene c.2860C&#x0003e;T mutation in congenital fibrosis of extraocular muscles type 1 and 3. <span><span class="ref-journal">Mol Vis. </span>2005;<span class="ref-vol">11</span>:245–8.</span> [<a href="/pubmed/15827546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15827546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.liu.2014.15">Liu G, Chen X, Sun X, Liu H, Zhao K, Chang Q, Pan X, Wang X, Yuan S, Liu Q, Zhao C. Maternal germline mosaicism of kinesin family member 21A (KIF21A) mutation causes complex phenotypes in a Chinese family with congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Mol Vis. </span>2014;<span class="ref-vol">20</span>:15–23.</span> [<a href="/pmc/articles/PMC3888497/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3888497</span></a>] [<a href="/pubmed/24426772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24426772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.lu.2008.388">Lu S, Zhao C, Zhao K, Li N, Larsson C. Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3. <span><span class="ref-journal">Arch Ophthalmol. </span>2008;<span class="ref-vol">126</span>:388–94.</span> [<a href="/pubmed/18332320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18332320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.luk.2013.182">Luk HM, Lo IF, Lai CW, Ma LC, Tong TM, Chan DH, Lam ST. Congenital fibrosis of extraocular muscle type 1A due to KIF21A mutation: first case report from Hong Kong. <span><span class="ref-journal">Hong Kong Med J. </span>2013;<span class="ref-vol">19</span>:182–5.</span> [<a href="/pubmed/23535681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23535681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.mackinnon.2014.1461">MacKinnon S, Oystreck DT, Andrews C, Chan WM, Hunter DG, Engle EC. Diagnostic distinctions and genetic analysis of patients diagnosed with Moebius syndrome. <span><span class="ref-journal">Ophthalmology. </span>2014;<span class="ref-vol">121</span>:1461–8.</span> [<a href="/pmc/articles/PMC4082742/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4082742</span></a>] [<a href="/pubmed/24612975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24612975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.marszalek.1999.469">Marszalek JR, Weiner JA, Farlow SJ, Chun J, Goldstein LS. Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B. <span><span class="ref-journal">J Cell Biol. </span>1999;<span class="ref-vol">145</span>:469–79.</span> [<a href="/pmc/articles/PMC2185086/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2185086</span></a>] [<a href="/pubmed/10225949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10225949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.miyake.2010.215">Miyake N, Andrews C, Fan W, He W, Chan WM, Engle EC. CHN1 mutations are not a common cause of sporadic Duane's retraction syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:215–7.</span> [<a href="/pmc/articles/PMC2801889/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2801889</span></a>] [<a href="/pubmed/20034095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20034095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.miyake.2008.839">Miyake N, Chilton J, Psatha M, Cheng L, Andrews C, Chan WM, Law K, Crosier M, Lindsay S, Cheung M, Allen J, Gutowski NJ, Ellard S, Young E, Iannaccone A, Appukuttan B, Stout JT, Christiansen S, Ciccarelli ML, Baldi A, Campioni M, Zenteno JC, Davenport D, Mariani LE, Sahin M, Guthrie S, Engle EC. Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. <span><span class="ref-journal">Science. </span>2008;<span class="ref-vol">321</span>:839–43.</span> [<a href="/pmc/articles/PMC2593867/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2593867</span></a>] [<a href="/pubmed/18653847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18653847</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.morin.1997.411">Morin X, Cremer H, Hirsch MR, Kapur RP, Goridis C, Brunet JF. Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. <span><span class="ref-journal">Neuron. </span>1997;<span class="ref-vol">18</span>:411–23.</span> [<a href="/pubmed/9115735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9115735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.nakano.2001.315">Nakano M, Yamada K, Fain J, Sener EC, Selleck CJ, Awad AH, Zwaan J, Mullaney PB, Bosley TM, Engle EC. Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:315–20.</span> [<a href="/pubmed/11600883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11600883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.oegema.2015.5313">Oegema R, Cushion TD, Phelps IG, Chung SK, Dempsey JC, Collins S, Mullins JG, Dudding T, Gill H, Green AJ, Dobyns WB, Ishak GE, Rees MI, Doherty D. Recognizable cerebellar dysplasia associated with mutations in multiple tubulin genes. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:5313–25.</span> [<a href="/pmc/articles/PMC4550818/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4550818</span></a>] [<a href="/pubmed/26130693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26130693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.papakostas.2015.248">Papakostas TD, Le HG, Chodosh J, Jacobs DS. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis. <span><span class="ref-journal">Ophthalmology. </span>2015;<span class="ref-vol">122</span>:248–53.</span> [<a href="/pubmed/25282251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25282251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.pattyn.1997.4065">Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. <span><span class="ref-journal">Development. </span>1997;<span class="ref-vol">124</span>:4065–75.</span> [<a href="/pubmed/9374403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9374403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.pieh.2003.546">Pieh C, Goebel HH, Engle EC, Gottlob I. Congenital fibrosis syndrome associated with central nervous system abnormalities. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2003;<span class="ref-vol">241</span>:546–53.</span> [<a href="/pubmed/12819981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12819981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.poirier.2010.4462">Poirier K, Saillour Y, Bahi-Buisson N, Jaglin XH, Fallet-Bianco C, Nabbout R, Castelnau-Ptakhine L, Roubertie A, Attie-Bitach T, Desguerre I, Genevieve D, Barnerias C, Keren B, Lebrun N, Boddaert N, Encha-Razavi F, Chelly J. Mutations in the neuronal &#x000df;-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:4462–73.</span> [<a href="/pmc/articles/PMC3298850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3298850</span></a>] [<a href="/pubmed/20829227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20829227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.reck.1998.676">Reck AC, Manners R, Hatchwell E. Phenotypic heterogeneity may occur in congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Br J Ophthalmol. </span>1998;<span class="ref-vol">82</span>:676–9.</span> [<a href="/pmc/articles/PMC1722617/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1722617</span></a>] [<a href="/pubmed/9797671" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9797671</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.rudolph.2009.667">Rudolph G, Nentwich M, Hellebrand H, Pollack K, Gordes R, Bau V, Kampik A, Meindl A. KIF21A variant R954W in familial or sporadic cases of CFEOM1. <span><span class="ref-journal">Eur J Ophthalmol. </span>2009;<span class="ref-vol">19</span>:667–74.</span> [<a href="/pubmed/19551685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19551685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.shimizu.2005.443">Shimizu S, Okinaga A, Maruo T. Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Jpn J Ophthalmol. </span>2005;<span class="ref-vol">49</span>:443–7.</span> [<a href="/pubmed/16365788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16365788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.shinwari.2015.147">Shinwari JMA, Khan A, Awad S, Shinwari Z, Alaiya A, Alanazi M, Tahir A, Poizat C, Al Tassan N. Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:147–52.</span> [<a href="/pmc/articles/PMC4289688/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4289688</span></a>] [<a href="/pubmed/25500261" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25500261</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.tiab.2004.241">Tiab L, d'Alleves Manzi V, Borruat FX, Munier F, Schorderet D. Mutation analysis of KIF21A in congenital fibrosis of the extraocular muscles (CFEOM) patients. <span><span class="ref-journal">Ophthalmic Genet. </span>2004;<span class="ref-vol">25</span>:241–6.</span> [<a href="/pubmed/15621876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15621876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.tischfield.2010.74">Tischfield MA, Baris HN, Wu C, Rudolph G, Van Maldergem L, He W, Chan WM, Andrews C, Demer JL, Robertson RL, Mackey DA, Ruddle JB, Bird TD, Gottlob I, Pieh C, Traboulsi EI, Pomeroy SL, Hunter DG, Soul JS, Newlin A, Sabol LJ, Doherty EJ, de Uzc&#x000e1;tegui CE, de Uzc&#x000e1;tegui N, Collins ML, Sener EC, Wabbels B, Hellebrand H, Meitinger T, de Berardinis T, Magli A, Schiavi C, Pastore-Trossello M, Koc F, Wong AM, Levin AV, Geraghty MT, Descartes M, Flaherty M, Jamieson RV, M&#x000f8;ller HU, Meuthen I, Callen DF, Kerwin J, Lindsay S, Meindl A, Gupta ML Jr, Pellman D, Engle EC. Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. <span><span class="ref-journal">Cell. </span>2010;<span class="ref-vol">140</span>:74–87.</span> [<a href="/pmc/articles/PMC3164117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3164117</span></a>] [<a href="/pubmed/20074521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20074521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.tischfield.2005.1035">Tischfield MA, Bosley TM, Salih MA, Alorainy IA, Sener EC, Nester MJ, Oystreck DT, Chan WM, Andrews C, Erickson RP, Engle EC. Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:1035–7.</span> [<a href="/pubmed/16155570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16155570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.tischfield.2011.286">Tischfield MA, Cederquist GY, Gupta ML Jr, Engle EC. Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations. <span><span class="ref-journal">Curr Opin Genet Dev. </span>2011;<span class="ref-vol">21</span>:286–94.</span> [<a href="/pmc/articles/PMC3100401/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3100401</span></a>] [<a href="/pubmed/21292473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21292473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.traboulsi.2004.237">Traboulsi EI, Engle EC. Mutations in KIF21A are responsible for CFEOM1 worldwide. <span><span class="ref-journal">Ophthalmic Genet. </span>2004;<span class="ref-vol">25</span>:237–9.</span> [<a href="/pubmed/15621875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15621875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.tukel.2005.408">Tukel T, Uzumcu A, Gezer A, Kayserili H, Yuksel-Apak M, Uyguner O, Gultekin SH, Hennies HC, Nurnberg P, Desnick RJ, Wollnik B. A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:408–15.</span> [<a href="/pmc/articles/PMC1736053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736053</span></a>] [<a href="/pubmed/15863670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15863670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.van_der_vaart.2013.145">van der Vaart B, van Riel WE, Doodhi H, Kevenaar JT, Katrukha EA, Gumy L, Bouchet BP, Grigoriev I, Spangler SA, Yu KL, Wulf PS, Wu J, Lansbergen G, van Battum EY, Pasterkamp RJ, Mimori-Kiyosue Y, Demmers J, Olieric N, Maly IV, Hoogenraad CC, Akhmanova A. CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor. <span><span class="ref-journal">Dev Cell. </span>2013;<span class="ref-vol">27</span>:145–60.</span> [<a href="/pubmed/24120883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24120883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.wabbels.2004.216">Wabbels BK, Lorenz B, Kohlhase J. No evidence of SALL4-mutations in isolated sporadic duane retraction "syndrome" (DURS). <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">131</span>:216–8.</span> [<a href="/pubmed/15386473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15386473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.wang.2011.973">Wang P, Li S, Xiao X, Guo X, Zhang Q. KIF21A novel deletion and recurrent mutation in patients with congenital fibrosis of the extraocular muscles-1. <span><span class="ref-journal">Int J Mol Med. </span>2011;<span class="ref-vol">28</span>:973–5.</span> [<a href="/pubmed/21805025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21805025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.wang.1998.517">Wang SM, Zwaan J, Mullaney PB, Jabak MH, Al-Awad A, Beggs AH, Engle EC. Congenital fibrosis of the extraocular muscles type 2, an inherited exotropic strabismus fixus, maps to distal 11q13. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:517–25.</span> [<a href="/pmc/articles/PMC1377321/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377321</span></a>] [<a href="/pubmed/9683611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9683611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.whitman.2016.297">Whitman MC, Andrews C, Chan WM, Tischfield MA, Stasheff SF, Brancati F, Ortiz-Gonzalez X, Nuovo S, Garaci F, MacKinnon SE, Hunter DG, Grant PE, Engle EC. Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170A</span>:297–305.</span> [<a href="/pmc/articles/PMC4770801/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4770801</span></a>] [<a href="/pubmed/26639658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26639658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.wu.2009.971">Wu L, Zhou LH, Liu CS, Cha YF, Wang J, Xing YQ. Magnetic resonance imaging features in two Chinese family with congenital fibrosis of extraocular muscles. <span><span class="ref-journal">Zhonghua Yan Ke Za Zhi. </span>2009;<span class="ref-vol">45</span>:971–6.</span> [<a href="/pubmed/20137413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20137413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yamada.2003.318">Yamada K, Andrews C, Chan WM, McKeown CA, Magli A, de Berardinis T, Loewenstein A, Lazar M, O'Keefe M, Letson R, London A, Ruttum M, Matsumoto N, Saito N, Morris L, Del Monte M, Johnson RH, Uyama E, Houtman WA, de Vries B, Carlow TJ, Hart BL, Krawiecki N, Shoffner J, Vogel MC, Katowitz J, Goldstein SM, Levin AV, Sener EC, Ozturk BT, Akarsu AN, Brodsky MC, Hanisch F, Cruse RP, Zubcov AA, Robb RM, Roggenkaemper P, Gottlob I, Kowal L, Battu R, Traboulsi EI, Franceschini P, Newlin A, Demer JL, Engle EC. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">35</span>:318–21.</span> [<a href="/pubmed/14595441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14595441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yamada.2004.2218">Yamada K, Chan WM, Andrews C, Bosley TM, Sener EC, Zwaan JT, Mullaney PB, Ozturk BT, Akarsu AN, Sabol LJ, Demer JL, Sullivan TJ, Gottlob I, Roggenkaemper P, Mackey DA, De Uzcategui CE, Uzcategui N, Ben-Zeev B, Traboulsi EI, Magli A, de Berardinis T, Gagliardi V, Awasthi-Patney S, Vogel MC, Rizzo JF 3rd, Engle EC. Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2004;<span class="ref-vol">45</span>:2218–23.</span> [<a href="/pubmed/15223798" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15223798</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yamada.2005.1254">Yamada K, Hunter DG, Andrews C, Engle EC. A novel KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and Marcus Gunn jaw-winking phenomenon. <span><span class="ref-journal">Arch Ophthalmol. </span>2005;<span class="ref-vol">123</span>:1254–9.</span> [<a href="/pubmed/16157808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16157808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yang.2010.2062">Yang X, Yamada K, Katz B, Guan H, Wang L, Andrews C, Zhao G, Engle EC, Chen H, Tong Z, Kong J, Hu C, Kong Q, Fan G, Wang Z, Ning M, Zhang S, Xu J, Zhang K. KIF21A mutations in two Chinese families with congenital fibrosis of the extraocular muscles (CFEOM). <span><span class="ref-journal">Mol Vis. </span>2010;<span class="ref-vol">16</span>:2062–70.</span> [<a href="/pmc/articles/PMC2965570/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2965570</span></a>] [<a href="/pubmed/21042561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21042561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yazdani.2003.861">Yazdani A, Chung DC, Abbaszadegan MR, Al-Khayer K, Chan WM, Yazdani M, Ghodsi K, Engle EC, Traboulsi EI. A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2). <span><span class="ref-journal">Am J Ophthalmol. </span>2003;<span class="ref-vol">136</span>:861–5.</span> [<a href="/pubmed/14597037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14597037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.yazdani.2004.1035">Yazdani A, Traboulsi EI. Classification and surgical management of patients with familial and sporadic forms of congenital fibrosis of the extraocular muscles. <span><span class="ref-journal">Ophthalmology. </span>2004;<span class="ref-vol">111</span>:1035–42.</span> [<a href="/pubmed/15121385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15121385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cfeom.REF.ying.2013.63">Ying M, Han R, Hao P, Wang L, Li N. Inherited KIF21A and PAX6 gene mutations in a boy with congenital fibrosis of extraocular muscles and aniridia. <span><span class="ref-journal">BMC Med Genet. </span>2013;<span class="ref-vol">14</span>:63.</span> [<a href="/pmc/articles/PMC3704937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3704937</span></a>] [<a href="/pubmed/23799907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23799907</span></a>]</div></li></ul></div></div><div id="cfeom.Chapter_Notes"><h2 id="_cfeom_Chapter_Notes_">Chapter Notes</h2><div id="cfeom.Author_Notes"><h3>Author Notes</h3><p>Dr Engle&#x02019;s websites: <a href="http://www.hhmi.org/scientists/elizabeth-c-engle" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hhmi.org</a>, <a href="http://dms.hms.harvard.edu/neuroscience/fac/Engle.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dms.hms.harvard.edu</a></p><p><a href="http://www.childrenshospital.org/research/labs/engle-laboratory" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Engle Laboratory</a></p></div><div id="cfeom.Author_History"><h3>Author History</h3><p>Caroline Andrews, MSc; Howard Hughes Medical Institute (2004-2016) <br />Jigar Desai, PhD; Children&#x02019;s Hospital Boston (2006-2011) <br />Elizabeth C Engle, MD (2004-present) <br />David G Hunter, MD, PhD (2006-present) <br />Mary Whitman, MD, PhD (2016-present)<br />Koki Yamada, MD, PhD; Children's Hospital Boston (2004-2006)</p></div><div id="cfeom.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 December 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for <i>PHOX2A</i></div></li><li class="half_rhythm"><div>28 July 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>KIF21A</i></div></li><li class="half_rhythm"><div>21 April 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 December 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available for CFEOM1</div></li><li class="half_rhythm"><div>22 September 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 April 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>7 January 2004 (ee) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1348</span><span class="label">PMID: <a href="/pubmed/20301522" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301522</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cftd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hepatic-fibrosis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1348&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1348/?report=reader">PubReader</a></li><li><a href="/books/NBK1348/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1348" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1348" style="display:none" title="Cite this Page"><div class="bk_tt">Whitman M, Hunter DG, Engle EC. Congenital Fibrosis of the Extraocular Muscles. 2004 Apr 27 [Updated 2016 Jan 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1348/pdf/Bookshelf_NBK1348.pdf">PDF version of this page</a> (567K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cfeom.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cfeom.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cfeom.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cfeom.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cfeom.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cfeom.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cfeom.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cfeom.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cfeom.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cfeom.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cfeom.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=347733[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TUBB2B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=401[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PHOX2A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55605[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KIF21A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10381[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TUBB3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488282" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488282" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488282" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488282" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301369" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Duane Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Duane Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Barry BJ, Whitman MC, Hunter DG, Engle EC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301347" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Myasthenic Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Abicht A, Müller J S, Lochmüller H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15747768" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.</a><span class="source">[Trans Am Ophthalmol Soc. 2004]</span><div class="brieflinkpop offscreen_noflow">Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Traboulsi EI. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Trans Am Ophthalmol Soc. 2004; 102:373-89. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15223798" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3).</a><span class="source">[Invest Ophthalmol Vis Sci. 2004]</span><div class="brieflinkpop offscreen_noflow">Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yamada K, Chan WM, Andrews C, Bosley TM, Sener EC, Zwaan JT, Mullaney PB, Oztürk BT, Akarsu AN, Sabol LJ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Invest Ophthalmol Vis Sci. 2004 Jul; 45(7):2218-23. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301522" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301522" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04121639a66ee2bab08eae">Congenital Fibrosis of the Extraocular Muscles - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Congenital Fibrosis of the Extraocular Muscles - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:51:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DD279E040775100000000046A019D&amp;ncbi_session=CE8DD279E0412151_1130SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1348%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1348&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1348/&amp;ncbi_pagename=Congenital Fibrosis of the Extraocular Muscles - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DD279E0412151_1130SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>